2005

Pfizer's 'What Are You Doing New Year's Eve?' Viagra Ad Encourages Use as 'Party Drug,' Says AHF: PRNewswire - December 30, 2005; -- AIDS Healthcare Foundation Calls Ad Campaign Reckless and Irresponsible and Urges World s Largest Pharmaceutical Company to Curb Direct to Consumer Drug Advertising LOS ANGELES, Dec. 30 /PRNewswire/ -- AIDS Healthcare Foundation, (AHF) the nation s largest AIDS group and a direct provider of HIV/AIDS medical care to
Huntington Hospital HIV Physician Leads Fourth Trip to Africa: PRNewswire - December 27, 2005; PASADENA, Calif., Dec. 27 /PRNewswire/ -- For the fourth time in the new millennium, a team of Huntington Hospital medical professionals, led by Kimberly Shriner, MD, will travel to Arusha, Tanzania (East Africa) bringing medical care and supplies to the Upone Charitable Medical Centre, an outpatient AIDS clinic. The
New Drug Application for Investigational HIV Protease Inhibitor TMC114 Submitted to U.S. Food & Drug Administration: PRNewswire - December 27, 2005; -- HIV/AIDS compound marks first regulatory submission by Tibotec Pharmaceuticals Ltd. CO CORK, Ireland , Dec. 27 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. today announced the submission of a New Drug Application to the United States Food and Drug Administration ( FDA ) for
AIDS Healthcare Foundation Calls on Gov. Schwarzenegger to Reverse 5% Medi-Cal Provider Cuts: 'Potentially Devastating' Cuts set to Take Effect January 1st: PRNewswire - December 21, 2005; LOS ANGELES, Dec. 21 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the United States , which currently operates free AIDS treatment clinics in the US, Africa and Central America -- including 12 free AIDS treatment clinics throughout California, joined the California Medical Associat
Calypte Expands Use of HIV-1 BED Incidence EIA Test: PRNewswire - December 21, 2005; LAKE OSWEGO, Ore., Dec. 21 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced the addition of dried blood spot samples as a new indication for use with the Calypte HIV-1 BED Incidence EIA. The Calypte HIV-1 BED Incidence EIA Dried Blood Spot Control Pack is now available as an accessor
On A Budget This Holiday Season? Shop at Boomerangs.: PRNewswire - December 20, 2005; BOSTON, Dec. 20 /PRNewswire/ -- Boomerangs, AIDS Action Committee s award- winning resale store, specializes in new and vintage clothing for men, women, and children. As well, Boomerangs offers a variety of affordable new and previously loved gifts, housewares, electronics and furniture. We have forged tremendous relat
2005 a Landmark Year for Adolescent Vaccines: Progress Paves the Way for Improved Protection: PRNewswire - December 19, 2005; NEW YORK, Dec. 19 /PRNewswire/ -- In the world of disease prevention, adolescents have traditionally gotten short shrift from the medical community. For years, adolescents have had little in the way of vaccine protection, but the year 2005 brought with it new vaccines for this age group, with many more pushing their wa
New Data Show Two-Thirds of Patients Achieve Undetectable Viral Load With FUZEON(R) and Investigational Protease Inhibitor: PRNewswire - December 19, 2005; WASHINGTON, Dec. 19 /PRNewswire-FirstCall/ -- New clinical data presented at the 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) demonstrate that the highest rates of viral suppression with an experimental boosted protease inhibitor (PI), TMC-114/ ritonav
Federal Grant Funds Research on Novel HIV Therapy: Award Supports Both Bench and Bedside Studies: PRNewswire - December 19, 2005; PHILADELPHIA, Dec. 19 /PRNewswire/ -- An immunology researcher at The Children s Hospital of Philadelphia leads a multi-center $6.7 million program project grant recently awarded by the National Institute of Mental Health (NIMH) to explore a novel approach to HIV treatment. Encompassing basic science research, animal s
Tibotec Presents Phase 2b Data on 2 Investigational HIV Compounds at ICAAC: TMC114 and TMC125 Demonstrate Activity Against Drug Resistant HIV: PRNewswire - December 19, 2005; WASHINGTON D.C., December 19 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. presented the primary 24-week efficacy and safety results from the POWER 2 trial on TMC114, a protease inhibitor (PI), in treatment-experienced patients and the first long-term clinical results of TMC125, a non-nucleoside reverse transcriptase in
Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows: PRNewswire - December 19, 2005; SPRING VALLEY, N.Y., Dec. 19 /PRNewswire/ -- Patients with HIV-associated unintended weight loss were shown to gain more weight, more rapidly when taking a daily regimen of megestrol acetate concentrated suspension 575 mg/5mL (MA-CS 575 mg/5 mL) than those patients receiving megestrol acetate oral suspension 800 mg/20
Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry Inhibitor: PRNewswire - December 17, 2005; -- TNX-355 Data Presented at 2005 ICAAC WASHINGTON, Dec. 17 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today presented data on its lead HIV drug candidate, TNX-355, at the American Society for Microbiology s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The presentation highlighted
Sangamo BioSciences Announces Breakthrough Results at ICAAC Demonstrating Protection of Cells From HIV Infection Following Treatment with Zinc Finger Nucleases: PRNewswire - December 17, 2005; -- CCR5 ZFP Therapeutic Expected to Enter Human Clinical Trials in 2006 RICHMOND, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that data from its program to develop a ZFP Therapeutic(TM) for HIV/AIDS were presented at the 45th Annual Interscience Conference on Antim
Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV Therapy: Company Presents In-Depth Analysis of TNX-355 Phase 2 Results at 45th ICAAC Meeting: PRNewswire - December 17, 2005; WASHINGTON, Dec. 17 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today presented further analysis of a Phase 2 study of its novel HIV antibody, TNX-355, in a late-breaking submission at the American Society for Microbiology s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The company,
GSK and Vertex Pharmaceuticals Announce Presentation of Data Supporting Development of Investigational HIV Protease Inhibitor Brecanavir: PRNewswire - December 16, 2005; -- Positive Data Presented at 45th Annual ICAAC CAMBRIDGE, Mass., Dec. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (GSK) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) presented positive results today from a study evaluating the safety, tolerability and antiviral activity of the investigational HIV-1 protease
More Than 100,000 People Unite to Support AIDS Prevention and Care Programs Through Bristol-Myers Squibb 2005 World AIDS Day Campaign: PRNewswire - December 16, 2005; -- Company s Annual Light to Unite Campaign Provides $100,000 for the National AIDS Fund WASHINGTON, Dec. 16 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today presented a $100,000 donation to the National AIDS Fund to provide funding for AIDS service organizations across the
SERONO LABS Pleads Guilty to the Illegal Marketing of AIDS Drug, Reports U.S. Attorney: PRNewswire - December 15, 2005; -- Company to pay $136.9 million criminal fine as part of $704 million global settlement BOSTON, Dec. 15 /PRNewswire/ -- The U.S. subsidiary, SERONO LABORATORIES, INC., of Swiss Corporation SERONO, S.A., pleaded guilty and was sentenced today in federal court on criminal charges in connection with several illegal schem
Monogram Presents Data Demonstrating Cost-Effectiveness of PhenoSense GT(TM) and Leadership in Advancing HIV Resistance Testing: PRNewswire - December 15, 2005; -- Five Abstracts Presented at ICAAC SOUTH SAN FRANCISCO, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Monogram BioSciences, Inc. (Nasdaq: MGRM) today announced the presentation of five abstracts related to its portfolio of HIV resistance assays at the 45th Annual Interscience Conference on Antimicrobial Agents and Chemot
GMHC Announces Departure Of Executive Director: PRNewswire - December 15, 2005; NEW YORK, Dec. 15 /PRNewswire/ -- Gay Men s Health Crisis (GMHC) today announced that its Executive Director, Ana Oliveira, will be leaving the agency to pursue other professional interests and that an interim Executive Director will be named by the Board of Directors in the next 30 days. Ana has been an outstanding as
AIDS Healthcare Foundation and Los Angeles County Department of Health Services Launch Partner Notification System: www.inSPOTLA.org: PRNewswire - December 14, 2005; What: Press Conference * AIDS Healthcare Foundation and the Los Angeles County Department of Health Services (DHS) to unveil http://www.inSPOTLA.org, a new website designed to facilitate partner notification, as well as access to testing and treatment services, in the Los Angeles area Who: Jonathan E. Fieldin
AIDS Action Committee Provides Utility Assistance for People Living with HIV/AIDS in Seven Counties: PRNewswire - December 14, 2005; -- Heat costs in New England expected to exceed last year s levels this winter; demonstrably affects low-income households at risk for homelessness BOSTON, Dec. 14 /PRNewswire/ -- Heating costs are expected to rise this winter over last year s cost levels and are already higher now than last year at this time. To ward
Medical Services Increases Presence in Middle East with Approvals in Lebanon: PRNewswire - December 13, 2005; EDMONTON, Alberta, Dec. 13 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC: MSITF) is pleased to announce that it has received regulatory approval to sell its VScan HIV 1&2 test kits in Lebanon . The distributor for Lebanon has already placed an order for in excess of 100,000 VScan HIV test kits
MedMira Completes CE Mark Facilities Inspection: PRNewswire - December 8, 2005; -- MiraCare Rapid HIV Antibody Test Poised for Sales in European Market HALIFAX, Dec. 8 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in flow-through rapid diagnostic technology, announced today that it has successfully completed its quality systems assess
Procyon receives regulatory approval to commence Phase 1 clinical trial for its lead HIV protease inhibitor, PPL-100: PRNewswire - December 8, 2005; -- Potentially high genetic barrier of PPL-100 makes it a promising candidate for first-line treatment of resistant HIV patients TICKER: PBP (TSX) MONTREAL, Dec. 8 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP), a biotechnology company developing innovative therapeutics in the fields of cancer and HIV/AIDS,
New IFPMA Survey highlights Major Contributions of Pharmaceutical Sector's Public-Private Health Partnerships in the Developing World: PRNewswire - December 7, 2005; -- Industry Programs Since Proclamation of Millennium Development Goals Have Provided More Than a Half-Billion Health Interventions Valued at $4.4 Billion GENEVA, Switzerland , December 7 /PRNewswire/ -- The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced the results of
AHF to Roll Out Frank, Unconventional 'HIV - Not Fabulous' Social Marketing & HIV Prevention Campaign in Los Angeles: PRNewswire - December 6, 2005; -- CDC-Funded, Two-year HIV Prevention Social Marketing Campaign Will Feature Graphic Images of AIDS Patients With a Simple Tagline Urging HIV Negative Gay Men to Stay Negative -- AIDS Healthcare Foundation, the Nation s Largest AIDS Group, to Oversee the Campaign Which is Backed by LA County s Office of AIDS Programs
GMAD Honors Notable Recipients for the Prestigious Charles Angel Awards: PRNewswire - December 2, 2005; NEW YORK, Dec. 2 /PRNewswire/ -- Gay Men of African Descent (GMAD) will host its 13th Annual Charles Angel Awards Dinner on Tuesday, December 6th to honor and showcase those who have made notable contributions to uplift, include and inform the nation about issues that affect our society. The event will Honor the Past -
Nigeria Successfully Implementing A National Blood Safety Program Led By Safe Blood for Africa Foundation(TM) To Fight The Spread of HIV/AIDS: PRNewswire - December 1, 2005; -- Nigerian President Olusegun Obasanjo Continues His Commitment To Transform Nigeria s Current Blood Transfusion System ABUJA, Nigeria, Dec. 1 /PRNewswire/ -- In a continuing effort in his commitment to transform Nigeria s blood transfusion system, His Excellency and Head of the African Union, President Olusegun Obasa
HIV/AIDS Conference Shifts Focus from Education to Action: PRNewswire - December 1, 2005; -- Disturbing Voices Conference Turns Attention from Defining the Pandemic to Providing Practical Applications for Addressing Crisis Both Locally and Globally LAKE FOREST, Calif., Dec. 1 /PRNewswire/ -- Dr. Rick and Kay Warren concluded the second day of the Disturbing Voices International HIV/AIDS Conference at Saddle
Eudoxa: WTO Must Eradicate Tariffs on AIDS Medicines: PRNewswire - December 1, 2005; -- Swedish Think Tank Urges Hong Kong Ministerial to Address Regressive Nature of Tariffs on Medicines STOCKHOLM, Sweden , Dec. 1 /PRNewswire/ -- The WTO must mark World AIDS Day by calling for the elimination of tariffs on AIDS medicines says Swedish Think Tank Eudoxa.
'Silence Is Deadly, And So Is Ignorance': Dr. Rick Warren Tests Negative For HIV, But Positive for Determination: PRNewswire - December 1, 2005; LAKE FOREST, Calif., Dec. 1 /PRNewswire/ -- Dr. Rick Warren voluntarily submitted to a free HIV screening in front of media and staffers at a World AIDS Day press briefing today, which closed out the Disturbing Voices HIV/AIDS Conference held at Saddleback Valley Community Church this week. I am taking this test public
Henan Province Opens First Blood Safety Training Center Through Joint Venture of Chinese Ministry of Health and U.S.-Based Safe Blood For China(TM) Foundation: PRNewswire - December 1, 2005; -- Vice Minister Huang Jiefu and Henan Health Department Officials Also Participate In Ribbon-Cutting Ceremony For New Center To Help Prevent Spread of HIV/AIDS HENAN PROVINCE, China, Dec. 1 /PRNewswire/ -- Taking a major step forward in the fight against HIV/AIDS in China, Vice Minister Huang Jiefu opened this week th
First Children's HIV/AIDS Medical Center Opens in Lesotho; Public-Private Partnership Provides Staffing, Funding: PRNewswire - December 1, 2005; -- Operated By Baylor College of Medicine and the Government of Lesotho ; Funded By Bristol-Myers Squibb s SECURE THE FUTURE(R) Initiative MASERU, Lesotho, Dec. 1 /PRNewswire-FirstCall/ -- The first medical center dedicated to caring for HIV/AIDS-infected infants and children in Lesotho, operated by Baylor College of M
Wyeth Enters into $32 Million Contract with National Institutes of Health (NIH) for Ongoing HIV Vaccine Research: PRNewswire - December 1, 2005; MADISON, N.J., Dec. 1 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, the pharmaceutical division of Wyeth (NYSE: WYE), has been awarded a five-year, $32 million contract from the Division of AIDS of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for
USAID's Telling Our Story Project Documents the Global HIV/AIDS Pandemic: PRNewswire - December 1, 2005; WORLD AIDS DAY 2005 WASHINGTON, Dec. 1 /PRNewswire/ -- Every day, the American people, through their compassion and generosity, provide needed, lifesaving assistance to vulnerable populations in developing countries, particularly those affected by HIV/AIDS. This year s theme for World AIDS Day on December 1 is Stop AID
KNOW HIV/AIDS Creates New PSAs Filmed at HIV/AIDS Support Groups in Los Angeles and El Salvador: PRNewswire - December 1, 2005; -- Viacom and the Kaiser Family Foundation Team Up With DDB Seattle to Develop New Documentary-Style PSAs in Support of World AIDS Day NEW YORK, Dec. 1 /PRNewswire-FirstCall/ -- As part of their KNOW HIV/AIDS public education initiative, Viacom Inc. and the Kaiser Family Foundation partnered with DDB Seattle to produce
Corporate Leaders, Government Officials and AIDS Experts Join HIV-Infected Youth in First-of-Its-Kind International Videoconference: PRNewswire - December 1, 2005; -- Panels of Young People in New Jersey and Uganda Sharing Stories of Hope and Challenges in Preventing and Treating HIV/AIDS NEWARK, N.J., Dec. 1 /PRNewswire/ -- Corporate leaders, government officials and experts in pediatric AIDS joined HIV-infected young people, including Elizabeth Glaser s son Jake Glaser, in Car
Remarks by President Bush and Mrs. Bush on World AIDS Day: PRNewswire - December 1, 2005; WASHINGTON, Dec. 1 /PRNewswire/ -- The following is a transcript of remarks by President Bush and Mrs. Bush on World AIDS Day: Room 450 -- Dwight D. Eisenhower Executive Office Building 10:08 A.M. EST MRS. BUSH: Good morning, everyone. Good morning and thank you all very, very much for joining us on this important day,
Statement by Mike Leavitt, Secretary of Health and Human Services, Regarding World AIDS Day: PRNewswire - December 1, 2005; WASHINGTON, Dec. 1 /PRNewswire/ -- World AIDS Day 2005 reminds us of the tragic scope of the HIV/AIDS pandemic, the advances we have made -- and, most importantly, the work yet to be done. We in this department and across the federal government, under President Bush s leadership in the fight against AIDS, mark this day
Celebrities and leaders in the fight against HIV/AIDS join forces with Cole, Viacom and the Kaiser Family Foundation to help erase stigma: PRNewswire - December 1, 2005; NEW YORK, Dec. 1 -- Kenneth Cole, in conjunction with KNOW HIV/AIDS, a joint public education initiative of Viacom Inc. and the Kaiser Family Foundation, today unveiled the We All Have AIDS campaign, which brings together key entertainment, political, social and scientific leaders in an effort to foster needed solidari
AIDS Action Committee Honors World AIDS Day 2005: PRNewswire - November 30, 2005; BOSTON, Nov. 30 /PRNewswire/ -- For this World AIDS Day, Dec. 1, 2005, AIDS Action Committee of Massachusetts, Inc. (AAC): * Makes http://www.aac.org the Go to site to navigate World AIDS Day events * Manages Living our Lives, HIV Conference for Women as part of a 10- agency collaboration * Offers contact for media wit
PacifiCare Partners With NCLR/CSULB Center for Latino Community Health and the Latino Coalition Against AIDS to Educate Latinas About the Risk of AIDS: PRNewswire - November 30, 2005; * Latinas and HIV/AIDS Summit at University Student Ballroom at California State University, Long Beach * Leading HIV/AIDS experts and other dignitaries/celebrities including U.S. Rep. Hilda Solis and actress Lupe Ontiveros to attend * World AIDS Day Dec. 1 LONG BEACH, Calif., Nov. 30 /PRNewswire/ -- The California Sta
Saddleback HIV/AIDS Conference Provides a 'Wake-Up Call and a 'Kick in the Butt' to the Church': PRNewswire - November 30, 2005; -- First-Ever Church-Sponsored International Health Conference Challenges Attendees to Show Compassion and Provide Relief to HIV/AIDS Victims Locally and Globally LAKE FOREST, Calif., Nov. 30 /PRNewswire/ -- Dr. Rick Warren and his wife Kay Tuesday opened the historic two-day Disturbing Voices HIV/AIDS conference -- th
AHF Global & 'LifeLine Durban' Unveil New Partnership at 'Ithembalabantu,' Free AIDS Clinic in South Africa: PRNewswire - November 30, 2005; -- Respected South African NGO Will Provide Social Services & Linkages to Complement Free AIDS Care and ARV Treatment at Clinic Run by US Largest AIDS Organization DURBAN, South Africa and LOS ANGELES, Nov. 30 /PRNewswire/ -- As nations around the world commemorate World AIDS Day, AIDS Healthcare Foundation (AHF) t
Wear the Red Ribbon on December 1: World AIDS Day: PRNewswire - November 30, 2005; ALEXANDRIA, Va., Nov. 30 /PRNewswire/ -- December 1 is World AIDS Day and activities throughout the globe will focus on education, outreach and awareness. This year, all people concerned with HIV/AIDS are encouraged to wear a red ribbon -- a sign of support for people living with HIV and a symbol of hope for the future
Number of Pills Affects Adherence to HIV Treatment Regimens: PRNewswire - November 30, 2005; -- Patients Taking Combination Pills Three Times More Likely to Refill Prescriptions on Time * HIV positive patients taking COMBIVIR achieved a >/= 95 percent adherence rate more than twice as often as patients taking lamivudine and zidovudine separately. * Mean adherence was higher for patients taking COMBIVIR (85 per
Global Business Coalition on HIV/AIDS Announces the Creation of a New Best Practice AIDS Standard for Corporate AIDS Programs: PRNewswire - November 29, 2005; NEW YORK, Nov. 29 /PRNewswire/ -- In response to growing demand from its 200 member companies, the Global Business Coalition on HIV/AIDS (GBC) announced today the creation of the first measurement system for business and AIDS -- a new Best Practice AIDS Standard for corporate HIV/AIDS programs. The Best Practice AIDS S
Halting HIV/AIDS Needs Bold Responses - World AIDS Day, 1 December: PRNewswire - November 29, 2005; MANILA, Philippines , Nov. 29 /Xinhua-PRNewswire/ -- Calling for genuine commitment and stronger political will, Dr Shigeru Omi, WHO Regional Director for the Western Pacific, today urged Member States to act boldly and urgently to change the course of the HIV/AIDS epidemic. Despite measures designed to prevent the
AnorMED announces enrollment of HIV patients into XACT study for AMD070 a first in class CXCR4 HIV entry inhibitor: PRNewswire - November 29, 2005; VANCOUVER, Nov. 29 /PRNewswire-FirstCall/ - AnorMED Inc. (AMEX:AOM; TSX:AOM) announced today the enrollment of HIV patients into its new clinical trial to evaluate the potential of AMD070 as a new anti-HIV drug. Novel anti-HIV targets are urgently needed. This is especially true for those HIV patients harboring types o
NIDA Unveils Campaign to Send Teens the Message About the Link Between Drug Abuse and HIV: PRNewswire - November 29, 2005; WASHINGTON, Nov. 29 /PRNewswire/ -- Drug Abuse and HIV: Learn the Link is the message of a new public awareness campaign announced November 29, 2005, by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Drug abuse prevention is HIV prevention, says NIDA Director Dr. Nora D.
4-year Delay on LA Bathhouse Regulations Continues as Infections Rise: PRNewswire - November 29, 2005; -- According to AHF, Despite Los Angeles County s Own Bathhouse Study Conducted in 2001-2002 at Two LA Area Bathhouses Which Showed an Alarming 11% HIV Positive Rate Among Men who Have Sex with Men (MSM), Bureaucratic Delays Stall Roll Out of County Health Regulations Calling for Better Access to HIV & STD Testing
First Blood Safety Training Center in Henan Province Opens Through Joint Venture of Chinese Ministry of Health and U.S.-Based Safe Blood for China(TM) Foundation: PRNewswire - Tuesday November 29; HENAN PROVINCE -- Taking a major step forward in the fight against HIV/AIDS in China, Vice Minister Huang Jiefu opened today the country s first joint venture blood safety training center in Henan Province funded and operated by the Washington DC-based Safe Blood International Foundation. He was joined in the launch ce
'DINE OUT ANN ARBOR' Unites Area Restaurants in the Fight Against AIDS, on Friday, December 2nd: PRNewswire - November 28, 2005; ANN ARBOR, Mich., Nov. 28 /PRNewswire/ -- What s on your plate Friday, December 2nd? DINE OUT ANN ARBOR will give area residents the opportunity to fight AIDS by doing something they frequently do: Eat Out! Nearly 50 restaurants from Ann Arbor and neighboring cities will participate in the Sixth Annual DINE OUT ANN ARB
World AIDS Day: 'Raising Awareness' is not Enough: Teleconference 11/29 at 1pm ET to Discuss 'Keeping the Promise' on AIDS: PRNewswire - November 28, 2005; WASHINGTON, Nov. 28 /PRNewswire/ -- World AIDS Day will be commemorated this Thursday, December 1, but AIDS experts are saying the event must go beyond raising awareness to holding President Bush, other world leaders, and the US Congress, to their promises. This year, Keeping the Promise is the global theme of World AI
Barbados Inaugural 'Passions Ball' Supports National HIV/AIDS Commission: PRNewswire - November 28, 2005; BRIDGETOWN, Barbados , Nov. 28 /PRNewswire/ -- On December 3, 2005, the Barbados Tourism Authority will unveil the inaugural Passions of Barbados Ball, at the Ronald Reagan Building, Washington DC. This unprecedented fundraising gala is in support of the National HIV/AIDS Commission of Barbados and proceeds will be pre
Enchanting Night On Ice To Support The Fight Against AIDS: Blades Against AIDS 3, a World AIDS Day Benefit for Body Positive: PRNewswire - November 28, 2005; NEW YORK, Nov. 28 /PRNewswire/ -- Lace up your glass slippers and join Body Positive at its annual fundraiser, Blades Against AIDS 3 . Skate the night away while raising valuable funds needed to fight HIV/AIDS. Co-produced by the New York City Gay Hockey Association, 64events.com and Out of Bounds, Blades Against AIDS
VH1 Observes World AIDS Day With Special Programming to Increase Awareness of the Silent Killer: HIV/AIDS Related Programming to Air Thursday, December 1, 2005: PRNewswire - November 28, 2005; -- VH1 Classic and VH1 Soul to Premiere VH1 News Presents: Tracking The Monster: Ashley Judd and India .Arie Confront AIDS in Africa NEW YORK, Nov. 28 /PRNewswire/ -- December 1, World AIDS Day is an international day of action for HIV/AIDS. While most families gear up for the holidays, VH1 will provide special program
'Celebrities Unite Against Aids' Press Conference: Beijing: PRNewswire - November 24, 2005; * Sent by WHO China on behalf of Positive Art Workshop BEIJING, Nov. 24 /Xinhua-PRNewswire/ -- For World AIDS Day 2005, Positive Art Workshop (PAW) and Hard Rock Cafe (HRC) are proud to co-organise the Unite Against AIDS campaign. A press conference -- Celebrities Unite Against AIDS is to be held on 28 November 2005 (
Boehringer Ingelheim Announces 48-Week Results from Aptivus(R) (tipranavir) RESIST Studies: PRNewswire - November 21, 2005; RIDGEFIELD, Conn., Nov. 21 /PRNewswire/ -- New data on Aptivus(R) (tipranavir) capsules from a 48-week combined analysis of the RESIST-1 and RESIST-2 studies were presented at the 10th European AIDS Conference (EACS) in Dublin. The RESIST trials are randomized, controlled, open-label Phase 3 trials designed to study AP
Drug Company Support is Critical to Advancing AIDS Prevention Effort: Statement by IPM CEO, Dr. Zeda Rosenberg, on New AIDS Statistics: PRNewswire - November 21, 2005; -- Joint United Nations Programme on HIV/AIDS ( UNAIDS ) Releases the UNAIDS/WHO 2005 AIDS Epidemic Update SILVER SPRINGS, Md., Nov. 21 /PRNewswire/ -- Zeda Rosenberg, Sc.D., Chief Executive Officer of the International Partnership for Microbicides (IPM), issued the following statement upon reviewing the 2005 AIDS Epid
UN's Latest World AIDS Stats Cast Pall on Global Efforts, Says AHF: PRNewswire - November 21, 2005; LOS ANGELES, Nov. 21 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest AIDS group which operates free AIDS treatment clinics in the US, Africa, Central America, and Asia, today expressed concern over the latest worldwide HIV/AIDS statistics, released earlier today in a joint report by the
African Nations Should Drop Debilitating Taxes and Tariffs on Medicines: PRNewswire - November 21, 2005; -- Failure to Compromise on Agricultural Subsidies in the WTO Gives African Nations Leadership Opportunity WASHINGTON, Nov. 21 /PRNewswire/ -- With the failure of the European Union, specifically the French to greatly reduce their agricultural tariffs, the African Union has a rare moment to assert its commitment to the
Statement of Dr. Musimbi Kanyoro, General Secretary, World YWCA; A Call to Action to Accelerate Worldwide Distribution of The Female Condom: PRNewswire - November 20, 2005; GENEVA, Nov. 20 /PRNewswire/ -- As World AIDS Day approaches, leaders of the YWCA across Africa are coming together to call on national governments and international donors to accelerate distribution of the female condom to women in developing countries. The global AIDS pandemic is rapidly evolving into a pandemic for
CDC's Latest HIV Stats Show Need for Stepped Up Prevention Efforts, Says AHF: HIV Rates Up 8% Among Gay Men, Down 5% Among African Americans: PRNewswire - November 18, 2005; -- US Largest AIDS Group Calls for Increased and More Innovative Prevention and Outreach; Notes HIV Rates Still Remain Highest Among Blacks, Who Were Eight Times as Likely as Whites to Be Diagnosed With HIV in 2004 LOS ANGELES, Nov. 18 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in t
Living Our Lives: A World AIDS Day Conference on Women to Occur in December: PRNewswire - November 18, 2005; BOSTON, Nov. 18 /PRNewswire/ -- On Thursday, December 1, 2005, World AIDS Day, a 10-member AIDS organization collaborative will host Living our Lives, an informational conference, featuring guest presentations and workshop sessions on various issues that affect women. The conference will be held at U Mass/Boston s new
New Data Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated Continued Efficacy and Favorable Resistance Profile for Patients Through Seven Years of Initial HIV Therapy: PRNewswire - November 18, 2005; DUBLIN, Nov. 18 /PRNewswire-FirstCall/ -- The longest clinical study of any HIV treatment -- seven years (360 weeks) -- of Kaletra (R) ( lopinavir / ritonavir )-based therapy study results demonstrated patients taking Kaletra in combinati
FDA Approves Updated Labeling for GSK's LEXIVA: PRNewswire - November 18, 2005; -- Co-administration With Esomeprazole Does Not Affect Blood Levels of LEXIVA RESEARCH TRIANGLE PARK, N.C., Nov. 18 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that the U.S. Food and Drug Administration ( FDA ) approved GSK s application to add clinical data to the prescribing information for
48-Week Clinical Trial Data Provides Information Regarding Switching from an Existing Protease Inhibitor-Based Regimen to a Reyataz(R) (atazanavir sulfate)-Based Regimen: PRNewswire - November 18, 2005; -- SWAN Study Key Results Presented at the Tenth European AIDS Conference DUBLIN, Ireland , Nov. 18 /PRNewswire-FirstCall/ -- In a 48-week study presented today at the Tenth European AIDS Conference (EACS), 7% of HIV-1- infected patients who switched from a stable, protease inhibitor-based (PI) anti-HIV regimen to a re
Tibotec Announces Start of TMC125 Phase III Trials: PRNewswire - November 17, 2005; CORK, Ireland , November 17 /PRNewswire-FirstCall/ -- - Innovative Trial Design Offers Two Investigational Antiretrovirals in Combination Tibotec Pharmaceuticals Ltd. announced today the opening of its pivotal phase III clinical trial program for its investigational non-nucleoside reverse transcriptase (NNRTI), TMC125.
Transgene and the International AIDS Vaccine Initiative (IAVI) Sign Manufacturing Agreement: PRNewswire - November 17, 2005; STRASBOURG, France , November 17 /PRNewswire-FirstCall/ -- Transgene today announced its agreement with the International AIDS Vaccine Initiative (IAVI) for process development and manufacturing of an AIDS vaccine candidate for use in clinical trials. The vaccine candidate uses the Adenovirus-35 vector technology and e
BET Unveils World AIDS Day Programming Lineup as Part of the Rap-It-Up HIV/AIDS Public Education Initiative: PRNewswire - November 16, 2005; -- The Network Rounds Out 8th Year of Quality HIV/AIDS Programming with Premiere of 2005 Rap-It-Up/BASS Film MULTITUDE OF MERCIES on December 1 at 9:00 p.m. ET/PT WASHINGTON, Nov. 16 /PRNewswire/ -- BET and the Kaiser Family Foundation today announced a line up of special HIV-themed programming to mark World AIDS Day o
Procyon reports new data for its lead HIV protease inhibitor, PPL-100, showing a potentially high genetic barrier against the HIV virus: PRNewswire - November 16, 2005; -- Mutations developed against PPL-100 may potentially confer hypersensitivity to other HIV protease inhibitors TICKER:PBP (TSX) MONTREAL, Nov. 16 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP), a biotechnology company developing innovative therapeutics in the fields of cancer and HIV/AIDS, announced today r
Procyon to host conference call and webcast today to explain new data for PPL-100: Potentially high genetic barrier against the HIV virus: PRNewswire - November 16, 2005; -- Mutations developed against PPL-100 may potentially confer hypersensitivity to other HIV protease inhibitors TICKER: PBP (TSX) MONTREAL, Nov. 16 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX: PBP), a biotechnology company developing innovative therapeutics in the fields of cancer and HIV/AIDS, announced today
Defenders of Property Rights Optimistic Brazil is Backing Away from U.S. AIDS Drug Patent Threat: PRNewswire - November 16, 2005; -- Brazilian Health Minister Announces AIDS Situation Under Control, Not a TRIPS-defined Health Emergency in Statement to Country s Health Council WASHINGTON, Nov. 16 /PRNewswire/ -- Defenders of Property Rights (DPR) today announced its optimism that the Brazilian government has backed away from its threats to seize A
The Wide Open State - Now Wide Open for Emerging Technology: Recognized as an Important Treatment Tool, virco(R)TYPE HIV-1 Now Approved for Texas Medicaid: PRNewswire - November 15, 2005; RARITAN, N.J., Nov. 15 /PRNewswire/ -- The Texas Medicaid Program is now providing coverage for virco(R)TYPE HIV-1 with the current procedure code of 0023T, as of November 1, 2005. The decision to cover the predictive phenotype that utilizes bioinformatics technology also provides coverage for HIV genotypes and convent
Celgene Receives Approvable Letter From FDA for THALOMID(R) in Treatment of Newly Diagnosed Multiple Myeloma: PRNewswire - November 15, 2005; SUMMIT, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) today announced the U.S. Food and Drug Administration ( FDA ) issued an approvable letter in response to the Company s sNDA for multiple myeloma (MM). The FDA has requested revised product labeling with the specific indication of newly d
Gen-Probe Awarded Prestigious National Medal of Technology for Development of Nucleic Acid Tests for Blood Screening: PRNewswire - November 15, 2005; SAN DIEGO, Nov. 15 /PRNewswire-FirstCall/ -- President George W. Bush has named Gen-Probe Incorporated (Nasdaq: GPRO) a 2004 National Medal of Technology Laureate in recognition of the Company s pioneering work in developing innovative nucleic acid tests to safeguard the nation s donated blood supply from viruses such
Statement From AIDS Action Committee of Massachusetts, Inc. Executive Director, Rebecca Haag - Nov. 14, 2005: PRNewswire - November 14, 2005; BOSTON, Nov. 14 /PRNewswire/ -- We salute the House of Representatives for the strong statement made today to reduce the spread of HIV/AIDS by overwhelmingly passing statewide Pharmacy Access legislation which brings us closer to enacting this law that will save lives in Massachusetts, said Rebecca Haag, Executive Dire
Consumer Sexual Health Group Welcomes FDA Condom Guidelines, Seeks Refinements: PRNewswire - November 14, 2005; WASHINGTON, Nov. 14 /PRNewswire/ -- Condoms are an essential tool in reducing the risk of sexually transmitted infections, says James R. Allen, MD, MPH, president and CEO of the American Social Health Association (ASHA), and we respect the work of the FDA in crafting a science-based guideline that can serve as a basis
Body Positive Releases New HIV/AIDS Resource Directory: The Principal Source of Information for Individuals and Organizations: PRNewswire - November 14, 2005; NEW YORK, Nov. 14 /PRNewswire/ -- Body Positive announced today the availability of its 2006 HIV/AIDS Resource Directory -- the first new edition of this authoritative guide to services provided to people living with HIV/AIDS in the New York metro area in five years. At more than 40 indexed and cross-referenced pages a
International Concert Series to Raise Awareness and Funds for Children Affected by AIDS: PRNewswire - November 14, 2005; -- Ten Concerts to be Produced Bi-Annually at Exotic Wonders of the World; Proceeds to Benefit UNICEF and HIV/AIDS Charities NEW YORK, Nov. 14 /PRNewswire/ -- The 8th Wonder of the World, a leading entertainment company formed by Tantra and East West Entertainment, today announced they will produce a series of concerts
GLOBE Study Demonstrates Telbivudine Provides Significantly Greater Response on Antiviral Measures vs. Lamivudine in Patients With Chronic Hepatitis B, the 10th Leading Cause of Death Worldwide: PRNewswire - November 14, 2005; * Achieving early viral suppression is associated with improved clinical outcomes * 95% of telbivudine-treated patients who have undetectable virus at 6 months remain so at one year SAN FRANCISCO, Nov. 14 /PRNewswire/ -- Results from the ongoing GLOBE study demonstrate that the investigational drug telbivudine provides
Celebs Contribute to World AIDS Day Auction BID 2 BEAT AIDS: Begins December 1, 2005 to Benefit LIFEbeat: PRNewswire - November 14, 2005; -- Featuring Memorabilia From Tom Cruise, Kanye West, The Simpsons, Madonna, Britney, Mariah, Lil Kim, Joni Mitchell, 50 Cent, Brooke Shields & More! NEW YORK, Nov. 14 /PRNewswire/ -- LIFEbeat, the Music Industry Fights AIDS honors World AIDS Day on December 1st with BID 2 BEAT AIDS, an eBay auction featuring nearl
Pegasys(R) Shows Encouraging Interim Results for Hepatitis C Patients in Whom Peg-Intron(R) Therapy Failed: PRNewswire - November 11, 2005; -- Study Results May Offer New Hope for Patients Who Had Not Responded to Treatment SAN FRANCISCO, Nov. 11 /PRNewswire/ -- Roche announced today plans to present interim results from a study showing that re-treatment with Pegasys(R) (peginterferon alpha-2a) plus Copegus(R) (ribavirin, USP) reduced viral levels in hepat
New Studies with Pegasys(R) plus Copegus(R) in Hepatitis C Treatment to be Presented at AASLD Annual Meeting: PRNewswire - November 11, 2005; SAN FRANCISCO, Nov. 11 /PRNewswire/ -- A series of studies related to the treatment of hepatitis C with Pegasys(R) (peginterferon alpha-2a) plus Copegus(R) (ribavirin, USP) will be presented at the 56th American Association for the Study of Liver Disease (AASLD) annual meeting, which begins here today. The following st
HBO Films' Oscar(R)-Nominated 'YESTERDAY' About AIDS in Africa to Premiere at Woodruff Arts Center November 10: PRNewswire - November 10, 2005; -- HBO and Comcast Will Host Premiere of Dramatic Film in Partnership with AID Atlanta, Celebrate diversity Through the Arts and the National Black Arts Festival ATLANTA, Nov. 10 /PRNewswire/ -- Nominated for Best Foreign Language Film at the Oscars(R) this year, the HBO Films presentation of YESTERDAY will have its At
Worldwide Shortage of Glaxo's AIDS Drug, AZT, Alarms Patients, Advocates, Says AHF: PRNewswire - November 9, 2005; -- AIDS Healthcare Foundation Says Patent Protection Issues Led to Global Shortage of Glaxo s Life-saving AIDS Drug; Notes AZT Shortage Echoes Global Shortage of Bird Flu Drug, Tamiflu -- In Two Weeks, Patients in Africa, Elsewhere May Be Forced to Scramble to Find Non-AZT Drug Regimens; AIDS Group Alarmed That Patient
Syphilis Rates Among Gay Men Skyrocket, Notes AHF: PRNewswire - November 8, 2005; -- Men Who Have Sex With Men (MSM) Account for 64% of All Adult Syphilis Cases in 2004, Up From Only 5% in 1999. US Largest AIDS Group Calls for Stepped Up STD & HIV Prevention and Testing LOS ANGELES, Nov. 8 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates fr
Cellegy Announces Results of Data Monitoring Committee Review of Savvy(R) Ghana Phase 3 HIV Prevention Trial: PRNewswire - November 8, 2005; -- Safety Profile Satisfactory, But Recommendation to Discontinue Trial Because of Low HIV Seroconversion Rate in Trial Population -- Conference Call Scheduled for Tuesday, November 8th at 11:00am (Eastern) HUNTINGDON VALLEY, Pa., Nov. 8 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. (Nasdaq: CLGY) announced t
Clinical Care Options Launches Upgraded User Interface for Its Specialty Portals: PRNewswire - November 8, 2005; RESTON, Va., Nov. 8 /PRNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative interactive medical education for healthcare professionals, has launched a new version of its Web site with an improved user interface, making it easier and faster to access and navigate the state-of-the-art educa
Tanox to Present Two Abstracts on TNX-355 at 2005 ICAAC: PRNewswire - November 7, 2005; HOUSTON, Nov. 7 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) will present two abstracts on its novel HIV antibody, TNX-355, at the American Society for Microbiology s Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Dec. 16-19, 2005 in Washington, D.C. The presentations include a late-b
Worldwide Orphans Foundation Begins Treating Children in Ethiopia With HIV/AIDS: PRNewswire - November 7, 2005; NEW YORK, Nov. 7 /PRNewswire/ -- Worldwide Orphans Foundation (WWO) has received its final certification from the Ethiopian government and has begun to treat orphans with HIV/AIDS. The Ministry of Health designated Barlow House/WWO as a Center for Pediatric HIV/AIDS treatment in Addis Ababa. According to Dr. Jane Arons
Health Canada Approves INSTI(TM) for HIV Testing in Doctors' Offices: PRNewswire - November 7, 2005; RICHMOND, BC, Nov. 7 /PRNewswire/ - bioLytical(TM) Laboratories announced today, INSTI(TM) HIV, a rapid HIV test kit developed by the company, has received market approval from Health Canada . INSTI(TM) HIV is the only immediate detection kit available in Canada for use in a point-of-care setting such as a doctor s off
LabCorp(R) Launches Enhanced HIV Screening Assay: PRNewswire - November 7, 2005; -- Revolutionary Procedure Helps Identify Newly Infected HIV Patients Up to Six Weeks Sooner than Standard HIV Antibody Screening BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the introduction of an enhanced HIV Screening Assay t
Fattah Leads Congressional Effort to Clean Up Africa's Blood Supply: PRNewswire - November 4, 2005; WASHINGTON, Nov. 4 /PRNewswire/ -- In Sub-Saharan Africa 24.5 million individuals are living with HIV and every 25 seconds another person is infected with the disease. Blood transfusions are directly linked to the escalation in the number of HIV cases. Congressman Chaka Fattah (D-PA), a member of the powerful House App
Avian Flu: What's Missing from the White House Plan: PRNewswire - November 3, 2005; WASHINGTON, Nov. 3 /PRNewswire/ -- An analysis released today of the White House s Avian Flu Plan argues the plan offers far too little help to countries so they can respond to an outbreak before it reaches the US. It warns that unless the plan is broadened, America will not be safe and its moral credibility could be d
FDA Advisers to Discuss OraQuick Advance, First At-home HIV/AIDS Test Made by OraSure; Healthcare Industry Today Offers Extended News Coverage: PRNewswire - November 3, 2005; WASHINGTON, Nov. 3 /PRNewswire/ -- In an effort to popularize HIV testing, the U.S. Food and Drug Administration is considering whether to allow the use of the first HIV test a person can take entirely at home. The test, made by OraSure Technology, relies on a swab on the inside of the mouth and provides results in abo
Roche Announces Expansion of First Major Study to Examine Efficacy of Pegasys(R) in Hepatitis C Treatment in Latinos: PRNewswire - November 3, 2005; -- Roche Continues Commitment to Examining Treatment Options for All Patients - NUTLEY, N.J., Nov. 3 /PRNewswire/ -- Roche announced today that the company is investing more resources in treating the Latino community by expanding the largest study to date comparing hepatitis C treatment response rates in Latinos and no
Net 1 UEPS Technologies, Inc. Announces Net1/JSI Co-operation on HIV/AIDS Drug Distribution: PRNewswire - November 3, 2005; JOHANNESBURG, South Africa , Nov. 3 /PRNewswire-FirstCall/ -- On September 27, 2005, the Washington, D.C.-based President s Emergency Plan for AIDS Relief, through the U.S. Agency for International Development (USAID), announced a contract to strengthen the lifeline of essential drugs and supplies for people living wit
Clinical Data on Thalidomide Reported in Recurrent Epithelial Ovarian Cancer: PRNewswire - November 3, 2005; -- Oral Presentation at the Chemotherapy Foundation Symposium Reported 50% of Patients Achieved Overall Response in Median Progression Free Survival SUMMIT, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced today that preliminary clinical data was reported at the XXIII Chemotherapy Fou
South African TV Special 'Takalani Sesame's Talk to Me' Honored with Prestigious Japan Prize: PRNewswire - November 2, 2005; -- Independent Research Finds Parents Exposed to TV Special Twice as Likely to Talk to Their Kids About HIV and AIDS NEW YORK and CAPE TOWN, South Africa , Nov. 2 /PRNewswire/ -- Takalani Sesame Presents: Talk to Me, the TV special based on the multi-media initiative aimed at conveying messages about talking to childre
Study Identifies Several New Bacterial Species Associated With Common Infection in Women: PRNewswire - November 2, 2005; -- Research Has Implications for Improving Detection and Treatment of Bacterial Vaginosis and Other Infections With Multiple Bacterial Sources SEATTLE, Nov. 2 /PRNewswire/ -- Despite being one of the most common infections among women, scientists and doctors know little about the causes of bacterial vaginosis (BV), a u
Monogram Biosciences Announces Medicaid Coverage for HIV Drug Resistance Testing in Texas: PRNewswire - November 2, 2005; -- Thousands of Patients Now Eligible for Coverage for PhenoSense(TM) Testing, Which Can Significantly Improve Management of HIV Care SOUTH SAN FRANCISCO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that the Texas Medicaid Program has initiated a benefit coverage p
HBO Films' Oscar(R)-Nominated 'YESTERDAY' to Premiere at the Byron Carlyle Theater November 15: PRNewswire - November 2, 2005; -- HBO and the Miami International Film Festival to host Florida Premiere of Dramatic Film about AIDS in Africa -- Screening to be followed by conversation with HIV/AIDS educators including Dr. Marilyn Volker, university professor of sexuality, drawing parallels between AIDS in Africa and South Florida MIAMI, Nov. 2 /P
Chicago Afrobeat Project to Celebrate Debut Album with Two Performances at Martyrs' Live in Chicago on November 12, 2005: PRNewswire - November 1, 2005; CHICAGO, Nov. 1 /PRNewswire/ -- Chicago Afrobeat Project (CAbP) will celebrate the release of the band s first studio recording on November 12, 2005 with two shows at Martyrs located at 3855 N. Lincoln Ave. in Chicago, Ill. The 21+ evening performance will feature special guests Fareed Haque, Morikeba Kouyate, Howard L
Dynavax Initiates US-Based Phase 1 Clinical Trial of HEPLISAV(TM) Hepatitis B Vaccine in Dialysis Population: PRNewswire - November 1, 2005; BERKELEY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) announced the initiation of a Phase 1 clinical trial of HEPLISAV, its ISS-based hepatitis B (HBV) vaccine in patients with end-stage renal failure (pre-dialysis). The trial will be conducted at multiple centers in the
AHF Criticizes Abbott For AIDS Drug Price Hike: PRNewswire - October 31, 2005; LOS ANGELES, Oct. 31 /PRNewswire/ -- In response to the announcement by Abbott Laboratories Inc., that the new reformulation of its HIV/AIDS drug, Kaletra ( lopinavir / ritonavir ), has been approved
Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV: PRNewswire - October 31, 2005; -- New Nature study shows potential of entry inhibitor compounds as HIV prevention tool NEW YORK, Oct. 31 /PRNewswire/ -- In a first-of-its-kind joint announcement, two of the world s leading pharmaceutical companies, Merck & Co. , Inc. and Bristol-Myers Squibb have each announced today that they have signed se
Abbott Receives FDA Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulation for HIV Patients: PRNewswire - October 31, 2005; -- New formulation offers patients more convenient form of the leading HIV protease inhibitor . ABBOTT PARK, Ill., Oct. 31 /PRNewswire-FirstCall/ -- Abbott announced today that it has received U.S. Food and Drug Administration ( FDA ) approval for a new tablet formulation of its HIV protease inhibitor (PI)
Pamela Anderson, Linda Evangelista, Missy Elliott Among Celebrity Supporters of M.A.C Aids Fund Kids Helping Kids Holiday Card Program: PRNewswire - October 31, 2005; -- M.A.C Aids Fund Launches 11th Annual Kids Helping Kids Card Campaign with $250,000 Goal, Featuring Children s Artwork To Benefit Families in Africa NEW YORK, Oct. 31 /PRNewswire/ -- Kids Helping Kids is an annual holiday card initiative of the M.A.C AIDS Fund (M.A.F) with 100 percent of sales going to support pediat
July 4th HIV/AIDS Awareness Concert and Fundraiser Philadelphia Freedom Concert & Ball, Raised Net Total of $1.1 Million for Elton John AIDS Foundation and Dr. Magnus Hirschfeld Fund: PRNewswire - October 28, 2005; -- Regional AIDS Organizations Enthusiastic PHILADELPHIA, Oct. 28 /PRNewswire/ -- The July 4 Philadelphia Freedom Concert and Ball headlined by Sir Elton John, drew well over 500,000 people to the Benjamin Franklin Parkway, was seen by a television audience of over a half-million others and raised a net total of $1.1 m
Cellegy Announces Update to Savvy Phase 3 HIV Prevention Trials: PRNewswire - October 27, 2005; HUNTINGDON VALLEY, Pa., Oct. 27 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. (Nasdaq: CLGY) announced today that 100% enrollment has been achieved in the Savvy(R) (C31G vaginal gel) Phase 3 HIV prevention trial in Ghana based on current projected enrollment. A total of 2,142 subjects are now enrolled in Ghan
Schering-Plough Discontinues Phase II Study of Vicriviroc in Treatment-Naive HIV Patients, Continues Phase II Study in Treatment-Experienced HIV Patients: PRNewswire - October 27, 2005; KENILWORTH, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported that it has discontinued a Phase II study with its investigational CCR5 receptor antagonist, vicriviroc, used in combination with Combivir in treatment-naive HIV patients.
The MALE Center Launches New, Exciting Event Series in November: PRNewswire - October 26, 2005; BOSTON, Oct. 26 /PRNewswire/ -- Beginning Nov. 5, The MALE Center, AIDS Action Committee s new community resource and wellness center for gay and bisexual men in Boston, will host a series of monthly on-site events as part of a new program to serve the interests of gay and bisexual men in Boston. Once a week, each mont
AHF to Unveil New 'Yes On 79' Ad: 'Drug Companies Think Californians are Idiots': PRNewswire - October 26, 2005; -- 30-Second TV Ad Reminds Voters that the Drug Industry Backs $80 Million Campaign to Defeat the Health, Consumer and Senior Advocate-Backed Prop 79 WHAT:Roll Out of New TV Ad for Yes on Proposition 79 Campaign (Cheaper Drugs More Californians Can Count On) WHEN:Tomorrow, Thursday, October 27, 2005, 11:00 a.m. WHE
Mattel Announces Signature Partnership With Children Affected by AIDS Foundation (CAAF): PRNewswire - October 26, 2005; -- Partnership to Support the First International Program for CAAF Focused on Children Orphaned by AIDS EL SEGUNDO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Mattel, Inc. (NYSE: MAT) and the Mattel Children s Foundation today announced the launch of a global signature partnership with the Children Affected by AIDS Foun
AHF & AFABI to Open New, Free AIDS Clinic in Tijuana: PRNewswire - October 26, 2005; -- AIDS Healthcare Foundation (AHF) and Agencia Familiar Binacional, A.C. (AFABI) to Host Ribbon-cutting Ceremony and Clinic Dedication This Friday, October 28th at 3pm -- US Largest AIDS Group Joins Forces and Partners With Respected Local Mexican NGO to Extend HIV/AIDS Medical Care and Access to Life-saving Anti-retr
Entertainment Production Company -- 8th Wonder of the World -- Announces First of Ten Concerts Around the World to Raise Awareness for HIV/AIDS: PRNewswire - October 26, 2005; -- MTV Asia, YouthAIDS and Lou Pearlman Join Hands with 8th Wonder of the World Concert Series -- Kick off event at the Taj Mahal, February 25, 2006 NEW YORK, Oct. 26 /PRNewswire/ -- 8th Wonder of the World, a semi-annual concert series to benefit HIV/AIDS efforts will be hosted at the natural and man-made Wonders of t
Tanox Reports Positive Results From Phase 2 Clinical Trial of TNX-355, an Entry Inhibitor to Treat HIV: Trial Meets Primary Endpoint: PRNewswire - October 26, 2005; -- Drug Candidate Significantly Reduces Level of Virus in Treatment-Experienced Patients -- Company to Host Conference Call Today at 10 a.m., EDT HOUSTON, Oct. 26 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today reported positive Phase 2 clinical results of its novel HIV drug candidate, TNX-355. The 24-week r
Tibotec Announces U.S. Expanded Access Program for TMC114: Program Will Provide Early Access for HIV-1 Infected Patients Who Have Limited Treatment Options: PRNewswire - October 26, 2005; YARDLEY, Pennsylvania, October 26 /PRNewswire-FirstCall/ -- Tibotec Pharmaceuticals Ltd. announced today the opening of its expanded access program (EAP) for its investigational protease inhibitor (PI), TMC114, in the U.S. The program will provide access for HIV-1 infected patients who need the compound to construct a
Campaign to End AIDS Rally: PRNewswire - October 23, 2005; -- Monday, October 24, 2005 -- LOVE Park -- 11:00 a.m. -- Thousands of AIDS activists kicked off a 21-day march to Washington, D.C., as part of The Campaign to End AIDS ( http://www.c2ea.org ). PHILADELPHIA, Oct. 23 /PRNewswire/ -- On Monday, October 24, 2005, Philadelphians will have a unique chance to join numbers of
Family-Friendly Celebrity Fundraiser to Tackle L.A. Foster Care Crisis: PRNewswire - October 21, 2005; -- Celebrities Host 7th Annual Children s Circle Fundraiser to Benefit Programs for Kids With Chronic and Terminal Medical Conditions on October 23rd LOS ANGELES, Oct. 21 /PRNewswire/ -- This Sunday, October 23rd, families in the L.A. community will have the opportunity to make a difference in the lives of L.A. foster
New Harris Poll Finds Different Religious Groups Have Very Different Attitudes to Some Health Policies and Programs: PRNewswire - October 20, 2005; ROCHESTER, N.Y., Oct. 20 /PRNewswire/ -- A new Harris Poll finds that large majorities of the U.S. adult public support each of 12 different healthcare policies, programs and practices, including some which are highly controversial. However, people who consider themselves very religious or born-again Christians and, pa
Nigeria's Creditors Should be Ashamed, Says Global AIDS Alliance: PRNewswire - October 20, 2005; -- Nigeria to Send $12.4 Billion to World s Richest Nations WASHINGTON, Oct. 20 /PRNewswire/ -- Today Nigeria reached an agreement with its largest creditors, grouped in what is known as the Paris Club. The agreement will lead to the cancellation of a large portion of Nigeria s massive $35.9 billion debt, 85.8% of whic
GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner to Develop New TB Vaccine: PRNewswire - October 20, 2005; PARIS, Oct. 20 /PRNewswire-FirstCall/ -- GlaxoSmithKline Biologicals (GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) today announced a new public-private partnership to develop GSK Biologicals tuberculosis candidate vaccine Mtb72F/AS02A, which has shown promising results in preclinical studies. In
Distinguished Achievement Awards Go to Seven Leading Researchers for Groundbreaking Discoveries; $6.5 Million in No-Strings-Attached Grants Support 13 Scientists for Cutting Edge Biomedical Research Across Three Continents: PRNewswire - October 20, 2005; -- Freedom to Discover Program Recognizes Achievements and Encourages Risk-Taking by Scientists with Focus on Basic Science and New Therapies for Alzheimer s Disease, Obesity, HIV/AIDS and Cancer NEW YORK, Oct. 20 /PRNewswire/ -- Honoring groundbreaking achievements as well as supporting cutting-edge research are the t
India's HIV/AIDS Pandemic Threatens Economic and Social Fabric: PRNewswire - October 20, 2005; -- FXB President Demands Reforms to Strengthen Community Support for AIDS-Related Orphans CHENNAI, India , TAMIL, India and NADU, India, Oct. 20 /PRNewswire/ -- Albina du Boisrouvray, president of the Association Francois-Xavier Bagnoud (FXB), warned the 5th International Conference on AIDS India here today that withou
Sontra and EpiVax Form Research Collaboration to Develop Therapeutic Topical Vaccines: PRNewswire - October 20, 2005; -- EpiVax s HIV Vaccine to be Delivered Topically with SonoPrep Skin Permeation Device FRANKLIN, Mass. & PROVIDENCE, R.I., Oct. 20 /PRNewswire-FirstCall/ -- Sontra Medical Corporation (Nasdaq: SONT) and EpiVax, Inc. announced today that they have formed a research collaboration to investigate the topical delivery o
Maxygen Announces $14.4 Million in U.S. Government Funding to Advance HIV Vaccine Research: PRNewswire - October 20, 2005; REDWOOD CITY, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY) today announced that it has been awarded grants and a contract totaling $14.4 million from the National Institutes of Health (NIH) and the United States Department of Defense to advance research for development of a preventative HIV va
GlaxoSmithKline Initiates New HIV/AIDS Collaboration in Kenya: Improved Healthcare for Thousands Expected: PRNewswire - October 19, 2005; PHILADELPHIA, LONDON, and NAIROBI, Kenya , Oct. 19 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced a new $1.8 million program to improve and scale up HIV/AIDS healthcare services at 60 facilities in Kenya. The program, a collaboration with AMREF (African Medical and Research Foundation), Elizabeth
League Launches 'NBA CARES' Global Outreach Initiative Supporting Education, Youth and Family Development, and Health-Related Causes: PRNewswire - October 18, 2005; - The NBA, Players and Teams Commit To Raise $100 Million, Volunteer 1 Million Hours and Build 100 Youth Sites - NEW YORK, Oct. 18 /PRNewswire-FirstCall/ -- The NBA, its players and teams unveiled a new initiative called NBA CARES, Commissioner David Stern announced today. Through NBA CARES, the league, players and tea
Bioject Announces B2000 Technology to Be Used in Phase 2 NIH-Sponsored Clinical Trial for HIV Vaccine: PRNewswire - October 18, 2005; BEDMINSTER, N.J., Oct. 18 /PRNewswire-FirstCall/ -- Bioject Medical Technologies, Inc. (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, today announced that the company s needle-free technology for vaccine delivery will be used in a National Institutes of Health (NIH)- sponsored Phase 2 clinica
TB Alliance and Bayer Launch Historic Global Drug Trials for Tuberculosis: Phase II Trials to Study Potential of Moxifloxacin to Shorten TB Treatment: PRNewswire - October 17, 2005; -- Partners Commit to Affordable Pricing for Patients in the Developing World NEW YORK, and LEVERKUSEN, Germany , Oct. 17 /PRNewswire/ -- The Global Alliance for TB Drug Development (TB Alliance) and Bayer Healthcare AG today announced a partnership to coordinate a global clinical trial program to study the potential o
Procyon announces positive preclinical results for its lead HIV protease inhibitor, PPL-100: PRNewswire - October 17, 2005; MONTREAL, Oct. 17 /PRNewswire-FirstCall/ - Procyon Biopharma Inc. (TSX:PBP) today announced preclinical results from its lead HIV protease inhibitor, PPL-100, development program. The recently completed preclinical safety studies show that PPL-100 is a safe drug. Earlier this year, the company had reported on the favor
SERONO to Pay $704 Million for the Illegal Marketing of AIDS Drug, Reports U.S. Attorney: PRNewswire - October 17, 2005; BOSTON, Oct. 17 /PRNewswire/ -- Swiss corporation SERONO, S.A., together with its U.S. subsidiaries, SERONO, INC., SERONO HOLDING, INC., SERONO LABORATORIES, INC. and related entities ( SERONO ) have agreed to pay a total of $704,000,000 to resolve criminal charges and civil liabilities in connection with several illeg
Whistleblower AHF Applauds Serono's $704M Settlement With Government for Illegal Marketing of AIDS Drug, Serostim: PRNewswire - October 17, 2005; LOS ANGELES, Oct. 17 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment clinics in the US, Africa, Central America and Asia, including 14 clinics in California and Florida, today welcomed the news of multi-national drug giant, Serono Inc. s, sett
3rd Annual National Latino Aids Awareness Day Unites Over 46 States From Coast to Coast: PRNewswire - October 17, 2005; -- The Last Day Of Hispanic Heritage Month Will Be Reserved To Spread The Message: Love Your Life, Protect Yourself, Get Tested For HIV NEW YORK, Oct. 17 /PRNewswire/ -- To mark a special day of awareness and prevention against HIV/AIDS in the Latino community, the Latino Commission on AIDS and the Hispanic Federation,
New HIV/AIDS Care Center - Big Boost for The AIDS Support Organization (TASO) and Uganda Infrastructure: PRNewswire - October 14, 2005; -- Pfizer /TASO Partnership to Improve Training, Counseling, Treatment and Care for Thousands Living with HIV/AIDS MBARARA, Uganda , Oct. 14 /PRNewswire-FirstCall/ -- The AIDS Support Organization (TASO), with support from Pfizer Inc, opened a new AIDS counseling and training center here today that will play an importa
AHF Urges FDA to Fast Track Approval of Rapid HIV Test Kits for Home Use: PRNewswire - October 13, 2005; -- US Largest AIDS Organization Says Approval of Home Testing Could Improve HIV Prevention Efforts LOS ANGELES, Oct. 13 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), which offers free HIV/AIDS treatment at its 14 clinics in California and Florida and is the operator of the largest free alternative HIV testing progr
Hispanic Women and HIV/AIDS Focus of New Study Released in Celebration of National Latino AIDS Awareness Day: PRNewswire - October 13, 2005; WASHINGTON, Oct. 13 /PRNewswire/ -- Congressional and Latino community leaders announce highlights of The National Latino AIDS Awareness Day festivities and the release of a new study on Hispanic women and HIV/AIDS. National Latino AIDS Awareness day was founded to call for expansion of resources for preventing spread
Updated HIV/AIDS Treatment Guidelines Support Use of FUZEON Plus an Active Boosted Protease Inhibitor to Achieve New Treatment Goal: PRNewswire - October 13, 2005; -- DHHS Panel Revises Approach for Treatment Experienced Patients -- NUTLEY, N.J., Oct. 13 /PRNewswire/ -- Newly updated HIV/AIDS treatment guidelines issued by the Department of Health and Human Services (DHHS) support the use of FUZEON(R) ( enfuvirtide ) with an active boosted protease inhibitor (PI) in patients w
Bay Area Latinos Unite to Promote AIDS Awareness in the Latino Community: PRNewswire - October 13, 2005; OAKLAND, Calif., Oct. 13 /PRNewswire/ -- HIV causes AIDS, Ignorance Kills, Protect Yourself is the slogan that the Bay Area National Latino AIDS Awareness Day (BANLAAD) coalition has adopted for this year s National AIDS Awareness Day on October 15, 2005. BANLAAD is a coalition formed by a diverse group of agencies, he
Latino Town Hall Meeting in Los Angeles To Discuss Future of Ryan White AIDS Funding: PRNewswire - October 13, 2005; -- Representatives Hilda Solis and Grace Napolitano Speak on Behalf of the Congressional Hispanic Caucus in Recognition of Latino AIDS Awareness Day WASHINGTON, Oct. 13 /PRNewswire/ -- The Ryan White ACTION Campaign joins Bienestar Human Services on October 14 from 12:00 pm - 2:00 pm (PDT) in hosting a Latino Town Hall
Bureaucrats to Fund County Rent Hike With $1.6 Million Cut to AIDS Services: PRNewswire - October 12, 2005; -- AIDS Healthcare Foundation Denounces Perverse Funding Priorities LOS ANGELES, Oct. 12 /PRNewswire/ -- Los Angeles County bureaucrats charged with distributing federal emergency AIDS funds sent a letter to community clinics and service providers on Friday informing them of $1.6 million in funding reductions to offset
Koronis Pharmaceuticals Begins Phase 1b Clinical Trial of Novel Anti-Viral HIV/AIDS Therapeutic in HIV-Positive Patients: PRNewswire - October 12, 2005; SEATTLE, Oct. 12 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the initiation of a Phase 1b clinical trial of KP-1461, its novel anti-viral therapeutic, in HIV-positive patients. The objectives of the trial are to evaluate the safety, toxicity, pharmacokinetic profile and initial clinical activity of KP
Arizona Health Leaders Gather in Tucson to Discuss New Methods for Protecting Women from HIV: PRNewswire - October 12, 2005; TUCSON, Ariz., Oct. 12 /PRNewswire/ -- HIV/AIDS service providers, scientists, medical experts, health activists and policy makers from across Arizona met today with one of the world s leading HIV/AIDS researchers to discuss new strategies to halt the growing AIDS epidemic in women. Women account for nearly half the 40
AHF to Offer Free HIV Testing for National Latino AIDS Awareness Day (NLAAD): PRNewswire - October 12, 2005; -- US Largest AIDS Organization Will Participate in Activities at Several California & Florida Sites Throughout This Week Leading Up to NLAAD, Saturday, October 15th LOS ANGELES, Oct. 12 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), which offers free HIV/AIDS treatment at its 14 clinics in California and Florid
Primagen and Roche Molecular Systems Initiate Discussions to Develop Dry Filter Spot Technology for HIV-1 Viral Load Testing in the Developing World: PRNewswire - October 11, 2005; AMSTERDAM, October 11 /PRNewswire/ -- Primagen Holding BV, The Netherlands and Roche Molecular Systems, Inc. (RMS), Pleasanton, California today announced the initiation of discussions about a development program to enable Primagen s Dry Filter Spot (DFS) technology to be used with RMS COBAS TaqMan Tests and AMPLICOR(
VIRxSYS Completes $30 Million Financing: Funds Will Support Phase II Trial for HIV/AIDS Therapy: PRNewswire - October 11, 2005; GAITHERSBURG, Md., Oct. 11 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing genetic therapies for HIV and cancer, announced the final closing of their latest financing round. The Series F Preferred Stock financing totaled approximately $31 million. Earlier closings of this round were used to com
Vical DNA Vaccine Technology Enters Phase 2 Clinical Trial for HIV: PRNewswire - October 11, 2005; SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) announced today the initiation of a National Institutes of Health (NIH) sponsored Phase 2 clinical trial of a prime-boost vaccine approach against HIV. The trial involves priming an immune response with multiple doses of a plasmid DNA vaccin
Global Attention Turns to Hospice and Palliative Care on October 8: PRNewswire - October 6, 2005; -- An important global event. - Archbishop Tutu ALEXANDRIA, Va., Oct. 6 /PRNewswire/ -- October 8, 2005 marks the first World Hospice and Palliative Care Day -- a unified day of action to raise awareness for the expansion of hospice and palliative care services around the world. Every year, millions of people around th
Nationwide Strengthening of Hospital System in Tanzania Marks New Era in Fight Against AIDS in Africa: PRNewswire - October 6, 2005; -- The Abbott Fund and the Government of Tanzania Dedicate New Hospital Facilities to Meet Long-Term Needs of Patients with HIV/AIDS and Other Diseases DAR ES SALAAM, Tanzania, Oct. 6 /PRNewswire/ -- In a ceremony today, Abbott CEO Miles White joined Tanzanian President Benjamin William Mkapa in dedicating a new state-
Clinical Care Options and the American Academy of HIV Medicine Announce Collaboration to Create Leading-Edge Educational Programs: PRNewswire - October 6, 2005; -- Agreement Aims to Help HIV Doctors Provide Optimal Patient Care - RESTON, Va., Oct. 6 /PRNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative interactive medical education for healthcare professionals, and the American Academy of HIV Medicine (AAHIVM), the premier professional associat
National Latino AIDS Awareness Day Will Go Ahead in Louisiana!: PRNewswire - October 5, 2005; NEW YORK, Oct. 5 /PRNewswire/ -- In spite of the devastation caused by Hurricane Katrina to Louisiana and the rest of the gulf coasts, the National Latino AIDS Awareness Day will continue as planned on Saturday, October 15, 2005 in Baton Rouge and in hundreds of other locations across the United States . The Nationa
Development of Starpharma's VivaGel(TM) Accelerated with $US20m Funding from NIH: PRNewswire - October 3, 2005; MELBOURNE, Australia , Oct. 3 /PRNewswire-FirstCall/ -- * Development of VivaGel(TM) significantly accelerated * Development costs externally funded through to the start of large-scale efficacy trials * No loss of product ownership or dilution of equity for Starpharma * Significant commercial opportunity exists for
Strengthening of Health Care Services and Infrastructure Critical but Neglected Factor in Access to Care for Millions of Africans: PRNewswire - October 3, 2005; -- Findings on Back Office Services Reported in the British Medical Journal PARIS, Oct. 3 /PRNewswire/ -- An article published today in the British Medical Journal highlights the need for more attention to broad-based and balanced strengthening of health care facilities in Africa. The importance of coordinated investme
One Week Remains Until The DIVA Foundation's Sheryl Lee Ralph Presents the 15th Annual 'DIVAS Simply Singing!' AIDS Benefit Saturday October 8th Wilshire Ebell Theatre: PRNewswire - September 30, 2005; -- Musical Gala Benefits AIDS Healthcare Foundation & The Black AIDS Institute LOS ANGELES, Sept. 30 /PRNewswire/ -- Sheryl Lee Ralph is at it again! Her 15th installment of DIVAS Simply Singing! to benefit AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment
His Excellency Yoweri Museveni, Uganda's President, to Dedicate New, Free AIDS Clinic in Masaka on October 6th, Notes AHF: PRNewswire - September 30, 2005; -- Expanded AIDS Facility, Which Provides Free Care and Anti-retroviral Treatment (ART), Plans to Scale Up Treatment to 4,000 Ugandans. Facility is an Innovative Partnership of the Ministry of Health, Republic of Uganda; AIDS Healthcare Foundation, and Uganda Cares. More Than 1,000 Uganda Cares Clients on Treatment Are
Female Health Company Announces International Availability of Second- Generation Female Condom at Significantly Lower Price: PRNewswire - September 30, 2005; -- New Study Shows Expanded Use of FC2 Could Prevent Thousands of HIV Infections and Save Millions of Dollars in Health Care Costs Annually in South Africa and Brazil Alone BALTIMORE, Sept. 30 /PRNewswire/ -- Mary Ann Leeper, Ph.D., President and COO of the Chicago-based Female Health Company (FHC), announced today tha
HIV-1 Virulence Attenuating - 75% of Viruses Less 'Fit' Than Those of 15 Years Ago: PRNewswire - September 29, 2005; LONDON, September 29 /PRNewswire/ -- 75% of samples taken from 2002-2003 were found to be weaker than those from 1986-1989, both in terms of spread within individuals and transmission to others, reports a recent AIDS journal article, published by Lippincott Williams & Wilkins - Replicative fitness of historical and
RESOURCE's Recovery Resource Center Receives Federal Funding for a Ground- Breaking Substance-Abuse, HIV/AIDS, and Hepatitis Prevention Program: PRNewswire - September 29, 2005; MINNEAPOLIS, Sept. 29 /PRNewswire/ -- RESOURCE s Recovery Resource Center (RRC) has just received a $1.7 million, five-year contract from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) to reduce the incidence of substance-abuse, HIV/AIDS, and hepatitis among communities of color and individ
M.A.C Cosmetics Receives the Global Business Coalition (GBC) on HIV/AIDS 2005 Award for Business Excellence at the Awards Gala Headlined by Secretary Condoleeza Rice, Senator Hilary Rodham Clinton and Academy Award Winner Angelina Jolie: PRNewswire - September 28, 2005; WASHINGTON, Sept. 28 /PRNewswire/ -- M.A.C Cosmetics is awarded the Global Business Coalition (GBC) 2005 Award for Business Excellence using Core Competency at the John F. Kennedy Center for the Performing Arts. This award will be presented on Wednesday September 28th at the GBC Annual Awards Gala emcee Academy Award W
Thousands With HIV/AIDS to Ride in Caravans to Washington, D.C. for Four Days of Protest and Prayer November 5-8: PRNewswire - September 28, 2005; -- Caravan Organizers to Assist People With HIV Displaced by Katrina WASHINGTON, Sept. 28 /PRNewswire/ -- Thousands of people living with HIV/AIDS are preparing to travel across the U.S. in ten activist caravans this October, stopping in more than 150 cities across the country to tell local and national leaders: We hav
De Beers Wins International HIV/AIDS Award: Global Business Coalition on HIV/AIDS Honors Companies' Efforts to Fight the Epidemic at Kennedy Center Gala: PRNewswire - September 28, 2005; WASHINGTON, Sept. 28 /PRNewswire/ -- Today De Beers is being honored for its workplace response to HIV/AIDS counseling and testing by the Global Business Coalition on HIV/AIDS (GBC) at its Annual Awards for Business Excellence Gala at the John F. Kennedy Center for the Performing Arts. UNHCR Goodwill Ambassador and act
Global Business Coalition on HIV/AIDS (GBC) Announces 2005 GBC Awards for Business Excellence Winners at Gala Headlined by Secretary Condoleezza Rice, Senator Hillary Rodham Clinton and Angelina Jolie: PRNewswire - September 27, 2005; -- Senators and CEOs to Discuss Improving Public-Private Collaboration to Combat the Global AIDS Pandemic at Hill Briefing -- Through Global AIDS Simulation, International AIDS Experts Demonstrate the Potential of Multisectoral Involvement in Stopping the Global AIDS Pandemic WASHINGTON, Sept. 27 /PRNewswire/ -- Global
Bristol-Myers Squibb Invites Others to Join in Expansion of Pediatric AIDS Corps in Africa: PRNewswire - September 27, 2005; PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- At an awards dinner in Washington D.C. tomorrow night, Bristol-Myers Squibb Company (NYSE: BMY) Chief Executive Officer Peter R. Dolan will invite other members of the Global Business Coalition on HIV/AIDS (GBC) to join Bristol-Myers Squibb and Baylor College of Medic
Lambs Farm Sued for Excluding Man Because of HIV-Positive Status: PRNewswire - September 27, 2005; -- Equip for Equality Seeks Damages and Injunction for Man Who Had Lived and Worked at Lambs Farm for Many Years CHICAGO, Sept. 27 /PRNewswire/ -- Equip for Equality today filed suit in federal court against The Lambs Farm, Inc. of Libertyville, Illinois, on behalf of a 54-year old man with a developmental disability w
Under the President's Emergency Plan for AIDS Relief, USAID Announces Contract to Swiftly Deliver Lifesaving Medicines and Supplies to Developing Countries: PRNewswire - September 27, 2005; -- Consortium of 15 Institutions to Implement Award WASHINGTON, Sept. 27 /PRNewswire/ -- Today, the President s Emergency Plan for AIDS Relief, through the U.S. Agency for International Development, announced a contract to strengthen the lifeline of essential drugs and supplies for people living with or affected by HIV
Medical Services to Begin Shipping VScan Tuberculosis (TB) Rapid Test Kits to Africa: PRNewswire - September 27, 2005; EDMONTON, Alberta, Sept. 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC: MSITF) wishes to announce that it has begun to ship its VScan (TB) rapid test kits to Africa. The World Health Organization (WHO) has declared a tuberculosis (TB) emergency for Africa. This epidemic kills more than 500,000 A
KNOW HIV/AIDS Seeks to Normalize HIV Testing With Its Latest Message 'The KNOW Is Spreading': PRNewswire - September 27, 2005; -- Viacom and Kaiser Family Foundation s Initiative, Featuring Grammy Award-Winning Hip-Hop Artist Common, Launches New Campaign Wave Across Multiple Platforms NEW YORK, Sept. 27 /PRNewswire/ -- As part of their Emmy and Peabody Award-winning public education initiative KNOW HIV/AIDS, Viacom Inc. and the Kaiser Family
Feds Approve AIDS Healthcare Foundation's Innovative Managed Care Plan as a 'Medicare Advantage' Plan (MA): PRNewswire - September 26, 2005; -- In Response to the Medicare Modernization Act (MMA), AHF, Operator of One of the Nation s First Medicaid Managed Care Plans for People With AIDS, Sought Medicare Advantage Status for its Positive Healthcare Partners to Ensure Continuity of Life-saving Care and Services for Its Eligible Clients. AHF s Program is the
Schwarzenegger Bows to Drug Industry Cash, Says AIDS Healthcare Foundation: PRNewswire - September 23, 2005; -- CA Gov. Endorses Proposition #78, Pharma s Toothless, Voluntary Drug Discount Measure on November Ballot; Comes Out Against Proposition #79, Measure Backed by Health, Labor and Senior Groups -- While Drug Industry Has Pooled a Record-breaking $80 Million for California Measures, Schwarzenegger Remains Second Only to
IFPMA Improves Biomedical Data Transparency With Launch of First Worldwide Clinical Trials Portal: PRNewswire - September 21, 2005; GENEVA, Switzerland , September 21 /PRNewswire/ -- The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today announced the launch of its new IFPMA Clinical Trials Portal. Developed in conjunction with information technology leader IBM, it is the first internet search engine construct
New Documentary Underscores That Successful Treatment of HIV-Infected Children Is Possible in Resource-Limited Settings: PRNewswire - September 21, 2005; -- Program Highlights the Botswana /Baylor Children s Center of Excellence, the World s Largest Pediatric AIDS Treatment Center HOUSTON, Sept. 21 /PRNewswire/ -- Baylor College of Medicine announced today that the U.S.-based Discovery Health Channel will turn its lens on the smallest and often most overlooked victims o
Botswana's Available Safe Blood Supply Increases 100% With Safe Blood for Africa Foundation's Program: PRNewswire - September 21, 2005; -- A Major Success For Botswana s Ministry of Health through President Bush s PEPFAR, ACHAP and Safe Blood for Africa Foundation Programs in The Fight to Prevent HIV/AIDS GABORONE, Botswana, Sept. 21 /PRNewswire/ -- According to the most recent assessment of the blood supply in Botswana, there has been an effective 100
Project HOPE's Director, HIV/AIDS Programs Receives International Honor: PRNewswire - September 20, 2005; MILLWOOD, Va., Sept. 20 /PRNewswire/ -- Project HOPE congratulates Dr. Renslow Sherer, Director, HIV/AIDS/Sexually Transmitted Infections Programs, on a remarkable recognition by his peers. On the occasion of its 10th anniversary, the International Association of Physicians in AIDS Care (IAPAC) has selected, from its m
Ranbaxy Receives Approval to Market Zidovudine Tablets: PRNewswire - September 20, 2005; PRINCETON, N.J., Sept. 20 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that it has received approval from the U.S. Food and Drug Administration to manufacture and market Zidovudine Tablets USP, 300 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formu
WHO Regional Director Highlights the Rise in New Emerging Diseases: PRNewswire - September 19, 2005; NOUMEA, New Caledonia , Sept. 19 /Xinhua-PRNewswire/ -- Dr Shigeru Omi, WHO Regional Director for the Western Pacific, today called for an all-out war on avian influenza and warned of the threat of new emerging diseases. While we still have a window of opportunity, we must do everything we can to avert an influenza pan
Glaxo's Patent Protection on First AIDS Drug, AZT, ends; AHF Blasts Glaxo's & Drug Industry's Greed: PRNewswire - September 17, 2005; -- US Largest AIDS Group Vows to Continue Its AZT Patent Piracy Lawsuit Against British Drug Giant, Says Glaxo s Action and Position on Patents for Life-saving AIDS Drugs, Too Little, Too Late LOS ANGELES, Sept. 17 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates
Former President Clinton Opens the Clinton Global Initiative: PRNewswire - September 15, 2005; -- King Abdullah II, Prime Minister Blair and Secretary of State Rice Take Part in the CGI s Inaugural Opening Session Featuring the Unveiling of 4 Major Commitments Worth Over $200 Million NEW YORK, Sept. 15 /PRNewswire/ -- Today, Former President William J. Clinton opened the Clinton Global Initiative, discussing the
African First Ladies Unveil New Campaign to Fight AIDS: PRNewswire - September 15, 2005; -- Adults Responsible for Protecting Children From Infection NEW YORK, Sept. 15 /PRNewswire/ -- With more than half of the world s HIV/AIDS cases located in Africa and up to one in three adults living with HIV in some communities, the pandemic in this region has claimed millions of lives and put the lives of millions m
Calypte's Aware(TM) HIV-1/2 BSP Test Receives Zimbabwe Approval: PRNewswire - September 15, 2005; -- Regulatory Trials Of Aware(TM) BSP Generate 100% Accuracy LAKE OSWEGO, Ore., Sept. 15 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced that the Medical Laboratory & Clinical Scientists Council of Zimbabwe has issued notification that the Calypte Aware(TM) HIV-1/2 BSP rapid (bl
Prop 79 Supporters Kick-Off Campaign to Counter $75 Million Drug Industry Ad-Blitz: PRNewswire - September 14, 2005; -- Consumer, Health & Senior Advocates Kick-Off Yes on Prop 79 Campaign in Sacramento Today; Will Launch So Cal Grassroots Campaign With Opening of LA Field Office Tomorrow, September 15th WHAT: Yes on Proposition 79, So Cal Grassroots Campaign Kick-Off & LA Field Office Opening, featuring supporters from consu
Daytime Unites for Africa: Soap Operas Call Attention on Air to Aids Crisis: PRNewswire - September 14, 2005; NEW YORK, Sept. 14 /PRNewswire/ -- In an unprecedented display of unity in commitment, all nine daytime dramas on ABC, CBS and NBC have agreed to join together, over a ten-week period this fall, to call attention in their programming to the AIDS crisis in Africa. The Daytime Unites for Africa campaign was created by So
Remarks by President Bush at United Nations High-Level Plenary Meeting: PRNewswire - September 14, 2005; WASHINGTON, Sept. 14 /PRNewswire/ -- The following is a transcript of remarks by President Bush at a United Nations High-Level plenary meeting: United Nations Headquarters New York, New York -- 9:48 A.M. EDT THE PRESIDENT: Mr. Secretary General, Mr. President, distinguished guests, ladies and gentlemen: Thank you for t
Addressing AIDS a Key Topic at Clinton Global Initiative Meeting: PRNewswire - September 14, 2005; -- World Vision s President focuses on micro-loans for women and community care coalitions of volunteers for orphans NEW YORK, Sept. 14 /PRNewswire/ -- The AIDS pandemic and ways to address its impact on women and orphans will be explored this week by leaders in government, business and the non-profit sectors at the in
Data Safety Monitoring Board Recommends Continuation of Tanox's Phase 2 Clinical Trial of TNX-355 for Treatment of HIV: PRNewswire - September 13, 2005; -- No Safety Issues Cited During Planned Interim Review HOUSTON, Sept. 13 /PRNewswire-FirstCall/ -- An independent Data Safety Monitoring Board (DSMB) has reviewed a planned interim safety analysis of Tanox, Inc. s (Nasdaq: TNOX) Phase 2 clinical trial of TNX-355 for treatment of the human immunodeficiency virus (HIV)
AHF Continues to Provide Health Care Services to HIV-Positive Hurricane Evacuees: PRNewswire - September 12, 2005; -- US Largest AIDS Organization Treating Displaced HIV/AIDS Patients at Its Clinics in California & Florida LOS ANGELES, Sept. 12 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the U.S. which offers free AIDS treatment services at its 14 clinics in the U.S., today announced it is
AMCOL International (NYSE: ACO) Presents at European Medical Conference: Introduces Nano Bentonite With Antiviral Properties: PRNewswire - September 12, 2005; ARLINGTON HEIGHTS, IlL., Sept. 12 /PRNewswire-FirstCall/ -- AMCOL International Corporation (NYSE: ACO) announced today that test results of recently discovered anti-viral properties of nano bentonites will be jointly presented with Retroscreen Virology Ltd., a London-based research and testing facility. In this study,
Vical and NIH to Evaluate Enhanced-Delivery HIV Vaccine: PRNewswire - September 12, 2005; SAN DIEGO, Sept. 12 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced plans to develop and evaluate electroporation-enhanced delivery of therapeutic and preventive DNA vaccines against HIV under a Cooperative Research and Development Agreement (CRADA) with the Vaccine Research Center (VRC), Na
YouthAIDS Brings Celebrities and Dignitaries to DC to Raise Funds and Awareness: PRNewswire - September 12, 2005; WASHINGTON, Sept. 12 /PRNewswire/ -- The following is being issued by YouthAIDS: WHY: AIDS affects young people at a greater rate than any other group: Every 15 seconds, a young person between the ages of 15-24 becomes infected with HIV; 12 million young people aged 15 to 24 are now living with HIV/AIDS; HIV is the lea
Detroit Artists Unite in the Fight Against AIDS at Tenth Annual 'ART WORKS FOR LIFE' Sept. 24: PRNewswire - September 9, 2005; FERNDALE, Mich., Sept. 9 /PRNewswire/ -- Over 300 of Detroit s most prominent artists will donate original pieces of art to be auctioned at the tenth annual ART WORKS FOR LIFE. This exciting event will begin at 6:30 p.m. on Saturday, September 24, 2005 at Detroit s historic Masonic Temple to benefit the Midwest AIDS Pr
AIDS Activists Target Charlize Theron & PeTA: PRNewswire - September 8, 2005; -- ACT UP!, AIDS Healthcare Foundation, More Than 20 AIDS Activists Unveil Campaign Targeting Hypocrisy of Hollywood Stars: You Cannot Wear an AIDS ribbon and Call Yourself a PeTA Supporter LOS ANGELES, Sept. 8 /PRNewswire/ -- Two days before People For the Ethical Treatment of Animals (PeTA) holds its 25th anniversary
Calypte Biomedical's Rockville, Maryland Facility Approved for the Manufacture of its HIV-1 Urine EIA Screening Test: PRNewswire - September 8, 2005; LAKE OSWEGO, Ore., Sept. 8 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (Amex: HIV) today announced that the United States Food and Drug Administration ( FDA ) has approved the Company s Rockville facility as the manufacturing site for its HIV-1 Urine EIA screening test. In 1996, Calypte s HIV-1 Urine E
Global Business Coalition on HIV/AIDS Announces Condoleezza Rice, Hillary Rodham Clinton and Angelina Jolie as Headliners at the 2005 GBC Awards for Business Excellence Gala: PRNewswire - September 8, 2005; -- Awards Given to Global Companies Leading the Business Community s Fight Against AIDS NEW YORK, Sept. 8 /PRNewswire-FirstCall/ -- Secretary of State Condoleezza Rice, Senator Hillary Rodham Clinton and Academy-Award winning actress Angelina Jolie will headline the 2005 Global Business Coalition on HIV/AIDS (GBC) Awar
The Founder of The AIDS Memorial Quilt Settles Legal Battle After Court Finds The NAMES Project Foundation Had Good Cause to Terminate Employment: PRNewswire - September 7, 2005; ATLANTA, Sept. 7 /PRNewswire/ -- The NAMES Project Foundation, the organization that cares for The AIDS Memorial Quilt, announced today that the legal dispute brought by Quilt founder, Cleve Jones, has been resolved. Jones agreed to withdraw his lawsuit only after the California Superior Court ruled in May and August 2
Panacos and Leading HIV Clinicians to Discuss PA-457 Clinical Trial Results: Analyst Briefing to be Held in New York on September 22, 2005: PRNewswire - September 7, 2005; WATERTOWN, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) ( Panacos or the Company ) today announced that it will hold a meeting for invited analysts and investment professionals on Thursday, September 22, 2005 from 8:00 am to 10:00 am at the St. Regis Hotel, Two East 55th Street,
IDM Announces Final Results of Phase 1 Therapeutic Aids Vaccine Study at Aids Vaccine 2005 International Conference: PRNewswire - September 7, 2005; SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (IDM) (Nasdaq: IDMI), formerly Epimmune Inc., today announced the final results of the Phase 1 clinical trial of its EP HIV-1090 DNA vaccine in 40 HIV-1-infected individuals with full suppression of HIV-1 replication on stable anti-retroviral therapy. Result
PA Early Stage Partners Forms Azidex Pharmaceuticals, Inc. with Seed Investment: Pittsburgh-Based Company's Compounds Attack Drug Resistant HIV: PRNewswire - September 7, 2005; PITTSBURGH, Sept. 7 /PRNewswire/ -- PA Early Stage Partners, a family of venture funds that makes investments in early stage life sciences and information technology companies, announced today that it has made a seed investment in Azidex Pharmaceuticals, Inc., a company focused on the development of new therapeutic com
Favorable Clinical Results Reported by CytRx for HIV Vaccine: PRNewswire - September 7, 2005; -- DNA/Protein Vaccine Candidate DP6-001 Demonstrates Ability to Produce Neutralizing Antibody Responses to Multiple AIDS Virus Strains LOS ANGELES, Sept. 7 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) today announced interim results from a Phase 1 clinical trial indicating that a novel HIV DNA + protein
President Bush Risks Breaking G8 Promise to Africa: PRNewswire - September 6, 2005; -- Global Civil Society Coalition Says the Global Fund s Funding Gap for HIV, TB and Malaria Will Cost the Lives of Millions LONDON, Sept. 6 /PRNewswire/ -- Final pledges of money to the replenishment of the Global Fund for HIV, TB and Malaria fell drastically short of what was needed to scale up the fight against thes
Wealthy and Educated Women Are the Most Vulnerable to HIV Infection in Cameroon: For 100 HIV Infected Men, There Are 170 Infected Women: PRNewswire - September 6, 2005; CALVERTON, Md., Sept. 6 /PRNewswire/ -- Seven percent of women in Cameroon are infected with HIV, compared with 4% among men, according to the latest Demographic and Health Survey (CDHS), conducted from February to August of 2004, the third DHS of its kind in this country. HIV-infected women are more likely to be educa
CA Headed for Last Place in HIV Reporting, Says AHF: PRNewswire - September 1, 2005; -- As Philadelphia Adopts Names-Based Reporting, California at Risk for Losing Tens of Millions; Nation s Largest AIDS Group Urges Swift Action by Legislature to Prevent Significant Loss of Federal HIV/AIDS Funding LOS ANGELES, Sept. 1 /PRNewswire/ -- Amid news that the City of Philadelphia has become the latest govern
Aug. 31st Press Briefing by Conference Call with Jeffrey Sachs - Upcoming Millennium + 5 World Summit, the Millennium Development Goals and Controversial U.S.-Proposed Revisions to Summit Document: PRNewswire - August 30, 2005; -- Is the U.S. backing off on commitments to health, education and poverty reduction and endangering/undermining global progress? WASHINGTON and NEW YORK, Aug. 30 /PRNewswire/ -- WHAT: A press briefing by conference call with economist Jeffrey Sachs on the upcoming September 2005 World Summit of 170 heads of state and
Interim HIV Vaccine Trial Results to be Presented at AIDS Vaccine 2005 International Conference: PRNewswire - August 30, 2005; LOS ANGELES, Aug. 30 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics primarily in the area of small molecules and ribonucleic acid interference (RNAi or gene silencing), today announced that preliminary interi
AIDS Healthcare Foundation to Donate 1 Million Condoms to Ugandan AIDS Fight: PRNewswire - August 29, 2005; -- US Largest AIDS Group Currently Operates 10 Free Uganda Cares AIDS Treatment Clinics Throughout Uganda; Clinics Are Operated in Partnership With Ugandan Ministry of Health LOS ANGELES, Aug. 29 /PRNewswire/ -- Based upon the revelation of a severe shortage of condoms in Uganda, long considered a worldwide model for A
Upward Spiral in AIDS Drug Prices Endangers Access, Says AHF: PRNewswire - August 29, 2005; -- $13K Per Year for Boehringer-Ingelheim s newest AIDS Drug Aptivus Reveals An Industry Out of Control ... and Totally Incapable of Self-Regulation Notes US Largest AIDS Group -- AHF Urges Californians to Demand Deeper Drug Discounts by Voting Yes on Prop. 79 in November LOS ANGELES, Aug. 29 /PRNewswire/ -- AIDS Healt
Arthur Ashe Stamp Dedicated at US Open: PRNewswire - August 27, 2005; NEW YORK, Aug. 27 /PRNewswire/ -- Humanitarian and world-class tennis player Arthur Ashe was immortalized on a postage stamp today when the U.S. Postal Service conducted a first-day-of-issue stamp dedication ceremony under the shadows of the stadium bearing his name. The ceremony took place as part of Arthur Ashe Kids
WHO Declares TB an Emergency in Africa: Call for 'Urgent and Extraordinary Actions' to Halt Worsening Epidemic: PRNewswire - August 26, 2005; MAPUTO, Mozambique , Aug. 26 /PRNewswire/ -- The World Health Organization (WHO) Regional Committee for Africa comprising health ministers from 46 Member States has declared tuberculosis an emergency in the African region -- a response to an epidemic that has more than quadrupled the annual number of new TB cases in mo
Living Well With HIV: A Long-Term Survivor Perspective: PRNewswire - August 25, 2005; HOUSTON, Aug. 25 /PRNewswire/ -- Nelson Vergel, a 22-year HIV survivor, international speaker and co-author of Built To Survive is visiting several US cities with Living Well With HIV, a comprehensive and free seminar on HIV treatments and side effect management for improved survival and quality of life. This seminar p
Building Stronger Health Systems Key to Reaching the Health Millennium Development Goals: PRNewswire - August 23, 2005; MANILA, Philippines , Aug. 23 /Xinhua-PRNewswire/ -- Building up and strengthening health systems is vital if more progress is to be made towards the Millennium Development Goals (MDGs), the World Health Organization (WHO) said in a new report. Unless urgent investments are made in health systems, current rates of prog
BET, Black AIDS Institute, Kaiser Family Foundation and YWCA Announce Winners of 2nd Annual Rap-It-Up/Black AIDS Short Subject Film Competition: PRNewswire - August 22, 2005; WASHINGTON, Aug. 22 /PRNewswire/ -- Concluding an extensive national call for submissions and thorough review process, BET, the Black AIDS Institute, Kaiser Family Foundation and YWCA proudly announce today that Let s Talk and Multitude of Mercies are the two winning screenplays of the 2nd Annual Rap- It-Up/Black AIDS
Panacos Drug Candidate PA-457 Shows Potent Antiviral Activity in HIV-infected Patients: Viral Load Reduction Meets Primary Endpoint of Phase 2a Study: PRNewswire - August 22, 2005; WATERTOWN, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) ( Panacos or the Company ), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the successful completion of a Phase 2a clinical study of its lead HIV drug
It's All Shiny And New VH1 Premieres/Encores For The Week Of August 19-August 25 2005: PRNewswire - August 19, 2005; NEW YORK, Aug. 19 /PRNewswire/ -- Check out all of the brand new premieres headed to VH1 and VH1 Classic this week. INDIA.ARIE AND ASHLEY JUDD EXPLORE THE WORLDWIDE STRUGGLE AGAINST HIV/AIDS VH1 NEWS PRESENTS: TRACKING THE MONSTER: ASHLEY JUDD AND INDIA.ARIE CONFRONT AIDS IN AFRICA A Special Highlighting VH1 s Partners
Popular AIDS Fundraising Thrift Store to Open New Bay Area Site at Folsom & 9th: Items from HBO's 'Six Feet Under' to Find New Life via Benefit Sale at AHF's Latest 'Out of the Closet' Store in San Francisco: PRNewswire - August 18, 2005; Donated Props & Set Pieces From the Nearly (and Dearly) Departed Cult TV Favorite Six Feet Under to Be Sold at Grand Opening, Saturday August 20th What: Ribbon Cutting/Grand Opening Sale at Out of the Closet s Newest Store Benefiting AIDS Healthcare Foundation When: Saturday August 20th 10:00am (store open 10-7pm)
Cure to HIV Doldrums Found at Sea: PRNewswire - August 18, 2005; MIAMI, Aug. 18 /PRNewswire/ -- Upon being diagnosed with HIV, many people experience a prolonged period of inaction, emotional paralysis and even depression. It doesn t have to be that way, says author Nelson Vergel, who knows first-hand that there is life beyond an HIV-positive diagnosis. With the right regimen of nut
India.Arie and Ashley Judd Explore The Worldwide Struggle Against HIV/AIDS 'VH1 News Presents: Tracking The Monster: Ashley Judd and India.Arie Confront AIDS in Africa': PRNewswire - August 18, 2005; A Special Highlighting VH1 s Partnership With The Global Fund To Fight AIDS, Tuberculosis and Malaria Premiering Tuesday, August 23 at 8PM* NEW YORK, Aug. 19 /PRNewswire/ -- AIDS: this health crisis has already taken the lives of over 20 million. Approximately 40 million people are living with HIV today. As part of its
Video Industry Event to Benefit the UCLA AIDS Institute: PRNewswire - August 17, 2005; -- Event for World s Leading HIV/AIDS Research Organization Sponsored by the PacifiCare Foundation LOS ANGELES, Aug. 17 /PRNewswire-FirstCall/ -- The Sideways Wine Tour, the Video Industry AIDS Action Committee s (VIAAC) third annual fund raiser benefiting the UCLA AIDS Institute, is being held this evening at 6:30 p.m
Hear No Evil? See No Evil? Speak No Evil?: KraftWorks Creates Celebrity Campaign for ALDO to Benefit YouthAIDS: PRNewswire - August 16, 2005; -- A-List Music and Hollywood Stars to Appear in Print and Outdoor Ads NEW YORK, Aug. 16 /PRNewswire/ -- ALDO, a global fashion footwear and accessories brand and retailer, and YouthAIDS, an HIV/AIDS education and prevention initiative, have partnered to create an international fundraising and awareness campaign to edu
MedMira Increases Product Registrations Internationally: PRNewswire - August 16, 2005; -- Rapid HIV and Hepatitis C Test Evaluations Underway in 24 Countries HALIFAX, Aug. 16 /PRNewswire-FirstCall/ - MedMira Inc., ( MedMira ) (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in rapid flow through diagnostic technology, announced today that it is registering its rapid HIV and combination HIV/hepa
ThinkQuest International 2006 Challenges Students to Build the Best Educational Web Site: PRNewswire - August 15, 2005; -- New Competition Now Open to Students and Teachers Worldwide REDWOOD SHORES, Calif., Aug. 15 /PRNewswire-FirstCall/ -- The Oracle Education Foundation today announced the opening of a new ThinkQuest competition, ThinkQuest International 2006, inviting students and teachers from around the world to take part in this u
MTV Announces New Documentary Special on The Poverty Crisis in Africa: 'The Diary of Angelina Jolie & Dr. Jeffrey Sachs in Africa': PRNewswire - August 15, 2005; -- Academy Award-Winning Actress/Social Activist Jolie and Renowned Economist Sachs Travel to Kenya To Explore Poverty - And To Inspire Young People To Take Action -- Timed to Coincide with U.N. Summit, Special Premieres on September 14 at 7 p.m., As Part of MTV s New Pro-Social Initiative think MTV NEW YORK, Aug.
Feds Say Half of Gay Men Who Have HIV Don't Know It, Notes AHF: PRNewswire - August 11, 2005; -- JAMA Article Reports on CDC Study That Showed 48% of Men Infected With HIV Were Unaware of Their Infection. AHF Says US HIV Testing System is Broken; Calls for Routine HIV Testing in Healthcare Settings, More Access to HIV Testing Overall LOS ANGELES, Aug. 11 /PRNewswire/ -- A recent Centers for Disease Control and
Malawi Facing Serious Food Crisis: More Than 4.2 Million People in Need of Assistance: PRNewswire - August 11, 2005; WASHINGTON and ROME, Aug. 11 /PRNewswire/ -- Malawi is facing its worst food crisis in more than a decade, the result of a combination of factors, including drought, floods, consecutive poor harvests, endemic poverty and the effects of the HIV/AIDS pandemic, FAO said today. More than 4.2 million people, or over 34 perc
AHF Awarded National ACCME Accreditation for Continuing Medical Education: PRNewswire - August 9, 2005; -- Honor Conferred by Prestigious Organization Enables the Nation s Largest AIDS Organization to Issue Continuing Medical Education Credits to HIV/AIDS Providers Nationwide LOS ANGELES, Aug. 9 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates free AIDS treatment cl
Philanthropist Mouli Cohen Funds Indiana University Program to Provide Food to Kenya's HIV Sufferers: PRNewswire - August 2, 2005; SAN FRANCISCO and INDIANAPOLIS, Aug. 2 /PRNewswire/ -- World-renowned philanthropist Mouli Cohen announced today a partnership with Indiana University s HAART and Harvest program, designed to provide food to HIV/AIDS patients in Kenya , Africa. Today the overwhelming number of HIV/AIDS cases in and around Kenya has cau
HIV Drug Resistance Test More Descriptive Than Ever - Virco Launches New HIV Resistance Report - The virco(R)TYPE HIV-1 Analysis Provides What Doctors Need to Assess New Options for Treatment-Experienced Patients: PRNewswire - August 1, 2005; RARITAN, N.J., Aug. 1 /PRNewswire/ -- Addressing the need for a more complete assessment upon which to base HIV treatment decisions, Virco BVBA, a leader in drug-resistance testing, is rolling out the virco(R)TYPE HIV-1 resistance analysis with clinical cutoffs. Described as a report card that includes a grade point av
Simple Screening Prevents Disease, Improves the Health of Young Women and Unborn ChildrenSimple Screening Prevents Disease, Improves the Health of Young Women and Unborn Children: PRNewswire - July 29, 2005; ROCKVILLE, Md., July 29 /PRNewswire/ -- Simple steps by health care institutions can increase the number of women tested for and diagnosed with chlamydia according to a study conducted by Kaiser Permanente, in partnership with the Centers for Disease Control (CDC) of Atlanta, Georgia. The analysis, which evaluated almo
Italian Jewelry Designer Roberto Coin Introduces 'Charm Bracelet' in Support of YouthAIDS: PRNewswire - July 29, 2005; NEW YORK, July 29 /PRNewswire/ -- Italian jewelry designer Roberto Coin has joined forces with YouthAIDS in their global incentive of raising funds and spreading the message of HIV/AIDS awareness to the world s youth population. Implemented through events and promotions, Roberto Coin has specially-designed a diamond ch
The Foundation for Innovative New Diagnostics (FIND) and Eiken Chemical Co. LTD. Announce Collaboration to Develop Rapid Diagnostic Test for Tuberculosis: PRNewswire - July 29, 2005; SEATTLE, July 29 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND), a Geneva-based non-profit funded by the Bill & Melinda Gates Foundation, and Eiken Chemical Co. Ltd., a Japan-based manufacturer of clinical diagnostics, today announced a collaboration to develop a rapid and simple test for the
AIDS Healthcare Foundation: HHS' Ryan White Reauthorization Plan Offers 'Vast Improvement in AIDS Care': PRNewswire - July 28, 2005; -- Nation s Largest AIDS Group Supports HHS Plan to Streamline Ryan White CARE Act. Government Redesign Calls for Increased Funding Levels for Life-Saving Medical Care, Particularly Among Underserved and Minority Populations, Reduction in Bureaucracy and Administrative Overhead. What: Press Conference & Teleconfere
AHF Calls CAFTA Win 'Devastating Loss' for Central Americans With HIV/AIDS: PRNewswire - July 28, 2005; -- Trade Agreement With Anti-Generic Drug Provisions Approved by House of Representatives Today in 217 to 215 Vote; Nation s Largest AIDS Organization Denounces Action and Calls on Global Community to Recognize HIV/AIDS as International Public Health Emergency WASHINGTON D.C., July 28 /PRNewswire/ -- AIDS advocates fro
Feds Signal Cutoff of AIDS Funds Over Faulty HIV Reporting System, According to AIDS Healthcare Foundation: PRNewswire - July 27, 2005; -- AHF Says California Could Lose Up to $50M Annually Unless It Scraps Current Code System. As Part of HHS Plan to Streamline Ryan White CARE Act, Officials Signal Intention to Require Reporting of HIV Cases by Individuals Names Rather Than Via Code-based system Beginning in Fiscal Year 2007. LOS ANGELES, July 27 /PRN
Current and Future Infectious Disease Threats: Developments in the Fight Against Infectious Diseases: PRNewswire - July 27, 2005; WASHINGTON, July 27 /PRNewswire/ -- Infectious diseases pose a serious threat to the nation s public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance
HHS Outlines President's Principles for Reauthorization of Ryan White CARE Act: PRNewswire - July 27, 2005; Comprehensive Approach Will Help Extend and Improve the Lives of Those Living With HIV/AIDS and Increase Prevention Efforts WASHINGTON, July 27 /PRNewswire/ -- At a meeting today with members of the President s Advisory Committee on HIV/AIDS, the CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment and a
Patient Satisfaction With Once-Daily Dosing Of HIV Fixed-Dose Combination Tablet EPZICOM: PRNewswire - July 27, 2005; At a Glance -- Patients taking an HIV regimen containing the fixed dose combination EPZICOM (abacavir and lamivudine) dosed once daily (QD) tended to be more satisfied with the convenience of their HIV regimens than those taking ZIAGEN (abacavir sulfate) + EPIVIR (lamivudine) separately twice daily. -- Several aspects
AHF Lauds Proposed White House Revamp of Nation's AIDS Program: PRNewswire - July 27, 2005; Nation s Largest AIDS Group Supports HHS Plan to Streamline Ryan White CARE Act. Government Redesign Calls for Increased Funding Levels for Life-Saving Medical Care, Particularly Among Underserved and Minority Populations, Reduction in Bureaucracy and Administrative Overhead. NOTE - MEDIA AVAILABILITY: Michael Weinstei
Nationwide Walk to Benefit Children With AIDS: PRNewswire - July 27, 2005; Local MannaWalk Events to Provide Nutritional Programs for Orphans With Epidemic Disease WHAT: On August 6, in big cities and small towns across the United States, people will unite and walk together to show their support for fighting HIV/AIDS in children across the globe. The new nationwide event, called MannaWalk, wi
Epimmune's Recombinant Protein HIV Vaccine Candidate to be Tested in Clinical Trials by the NIH Sponsored HIV Vaccine Trials Network: PRNewswire - July 26, 2005; SAN DIEGO, July 26 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), holds an active Investigational New Drug application (IND) from the FDA to test Epimmune s multi-epitope re
V.I. Technologies Presents Further Analysis of PA-457's Antiviral Activity Following a Single Oral Dose in HIV-infected Patients, at 3rd International AIDS Society Conference: PRNewswire - July 26, 2005; WATERTOWN, Mass., July 26 /PRNewswire-FirstCall/ -- V.I. Technologies ( Vitex ) and collaborators at the University at Buffalo s School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AID
Epimmune's Recombinant Protein HIV Vaccine Candidate to be Tested in Clinical Trials by the NIH Sponsored HIV Vaccine Trials Network: PRNewswire - July 26, 2005; SAN DIEGO, July 26 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), holds an active Investigational New Drug application (IND) from the FDA to test Epimmune s multi-epitope re
Long-Term Safety Data Of LEXIVA/R In HIV Patients Co-Infected With Hepatitis: PRNewswire - July 26, 2005; AT a GLANCE 120-week data from APV30002/APV30005 study of ART regimens containing LEXIVA/r: -- Median serum levels of ALT and AST, enzyme markers for liver disease, remained stable in 35 patients co-infected with hepatitis C or B. -- There were few new treatment-emergent Grade 3-4 ALT or AST toxicities observed betwe
Epidemiology Study Reports New Information on Hypersensitivity Reactions to Abacavir: PRNewswire - July 26, 2005; At a Glance -- Data from 11,586 patients who took an abacavir-containing product were obtained from four databases in this Epidemiology Study. -- Rechallenge with an abacavir-containing product in patients with a history of HSR or HSR-like events occurred in 18 of 11,586 (0.2%) patients in this study. -- Hospitaliz
Study Results Presented on Pharmacokinetics of Once-Daily HIV Combination Therapy -- Combination of LEXIVA/r and Truvada Evaluated: PRNewswire - July 26, 2005; RIO DE JANEIRO, Brazil , July 26 /PRNewswire/ -- An open label, single-arm study conducted among 15 HIV-positive patients evaluated the pharmacokinetic parameters of a once-daily combination of LEXIVA(R) ( fosamprenavir calcium), ritonavir and
AIDS Activists Cry Foul as Drug Companies Push Prices to Record Levels: PRNewswire - July 25, 2005; NEW YORK, July 25 /PRNewswire/ -- The following was released today by AIDS Treatment Activists Coalition: A steady onslaught of unreasonable, unacceptable, and unjustified increases in the price of therapies to treat HIV has caused activists in the US to accuse drugmakers of artificially inflating the market at the exp
Data on New Options to Improve FUZEON Self-Injection Presented at International AIDS Conference: PRNewswire - July 25, 2005; RIO DE JANEIRO, Brazil